<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS155875</article-id><article-id pub-id-type="doi">10.1101/2022.10.14.512296</article-id><article-id pub-id-type="archive">PPR558691</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group><subj-group subj-group-type="europepmc-category"><subject>Covid-19</subject></subj-group></article-categories><title-group><article-title>Disulfide stabilization reveals conserved dynamic features between SARS-CoV-1 and SARS-CoV-2 spikes</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Zhang</surname><given-names>Xixi</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Li</surname><given-names>Zimu</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Zhang</surname><given-names>Yanjun</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Liu</surname><given-names>Yutong</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Jingjing</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Banghui</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Qiuluan</given-names></name><xref ref-type="aff" rid="A3">3</xref><xref ref-type="fn" rid="FN1">6</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Qian</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Fu</surname><given-names>Lutang</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Peiyi</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Zhong</surname><given-names>Xiaolin</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Jin</surname><given-names>Liang</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Ling</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>He</surname><given-names>Jun</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Jincun</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A5">5</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib><contrib contrib-type="author"><name><surname>Xiong</surname><given-names>Xiaoli</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>State Key Laboratory of Respiratory Disease, CAS Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangdong Provincial Key Laboratory of Biocomputing, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, Guangdong, China</aff><aff id="A2"><label>2</label>State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China</aff><aff id="A3"><label>3</label>Bioland Laboratory (Guangzhou Regenerative Medicine and Health - Guangdong Laboratory), Guangzhou, Guangdong, China</aff><aff id="A4"><label>4</label>Cryo-electron Microscopy Center, Southern University of Science and Technology, Shenzhen, Guangdong, China</aff><aff id="A5"><label>5</label>Guangzhou Laboratory, Guangzhou International Bio Island, Guangzhou, Guangdong, China</aff><author-notes><fn fn-type="present-address" id="FN1"><label>6</label><p id="P1">Present address: Yunzhou Biosciences (Guangzhou) Co., Ltd., Guangzhou, Guangdong, China</p></fn><corresp id="CR1"><label>*</label>Correspondence: <email>xiong_xiaoli@gibh.ac.cn</email>, <email>zhaojincun@gird.cn</email>, <email>he_jun@gibh.ac.cn</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>19</day><month>10</month><year>2022</year></pub-date><pub-date pub-type="preprint"><day>16</day><month>10</month><year>2022</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P2">SARS-CoV-2 spike protein (S) is structurally dynamic and has been observed by cryo-EM to adopt a variety of prefusion conformations that can be categorized as locked, closed and open. The locked conformations feature tightly packed trimers with structural elements incompatible with RBD in “up” position. For SARS-CoV-2 S, it has been shown that the locked conformations are transient under neutral pH. Probably due to their transience, locked conformations remain largely uncharacterized for SARS-CoV-1 S. Intriguingly, locked conformations were the only conformations captured for S proteins of bat and pangolin origin SARS-related coronaviruses. In this study, we introduced x1, x2, and x3 disulfides into SARS-CoV-1 S. Some of these disulfides have been shown to preserve rare locked conformations when introduced to SARS-CoV-2 S. Introduction of these disulfides allowed us to image a variety of locked and other rare conformations for SARS-CoV-1 S by cryo-EM. We identified bound cofactors and structural features that are associated with SARS-CoV-1 S locked conformations. We compare newly determined structures to other available spike structures of Sarbecoviruses to identify conserved features and discuss their possible functions.</p></abstract></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P3">Betacoronavirus subgenus <italic>Sarbecovirus</italic> is composed of SARS-CoV-1, SARS-CoV-2 and other severe acute respiratory syndrome-related coronaviruses (SARSr-CoVs) (<xref ref-type="bibr" rid="R7">Coronaviridae Study Group of the International Committee on Taxonomy of Viruses 2020</xref>). Due to SARS-CoV-1’s known ability to infect humans and the SARS-CoV-2 pandemic, Sarbecoviruses are subjected to intense research. Among structural proteins of Sarbecoviruses, spike (S) protein is responsible for receptor binding and mediates membrane fusion between cell and virus to initiate infection (<xref ref-type="bibr" rid="R24">Li, 2016</xref>). Being the most exposed protein on the virus surface, it is the main target of immune system. Most available SARS-CoV-2 vaccines utilize S protein or its derivatives as the immunogen (<xref ref-type="bibr" rid="R22">Krammer, 2020</xref>) and a number of antibodies targeting the SARS-CoV-2 S protein have been approved for emergency use authorization (<xref ref-type="bibr" rid="R8">Corti <italic>et al</italic>, 2021</xref>). For these reasons, S protein is a major focus for coronavirus vaccine and therapeutics development.</p><p id="P4">Murine Hepatitis Virus (MHV) (<xref ref-type="bibr" rid="R41">Walls <italic>et al</italic>, 2016a</xref>), human coronavirus HKU1 (HCoV-HKU1) (<xref ref-type="bibr" rid="R19">Kirchdoerfer <italic>et al</italic>, 2016</xref>) and human coronavirus NL63 (HCoV-NL63) (<xref ref-type="bibr" rid="R42">Walls <italic>et al</italic>, 2016b</xref>) spikes were the first structurally characterized coronavirus (CoV) spikes. They all adopt single conformations with all their 3 receptor binding domains (RBDs) in “down” positions. Among Sarbecoviruses, structures of SARS-CoV-1 S protein were first determined and conformational dynamics was first observed for CoV spikes. RBDs in SARS-CoV-1 spikes were observed to be in “up” and “down” positions making the spikes exhibit open and closed conformations respectively (<xref ref-type="bibr" rid="R13">Gui <italic>et al</italic>, 2017</xref>; <xref ref-type="bibr" rid="R51">Yuan <italic>et al</italic>, 2017</xref>). In line with SARS-CoV-1 S, RBD “up” open and RBD “down” closed spikes were observed when SARS-CoV-2 S structures were initially determined (<xref ref-type="bibr" rid="R40">Walls <italic>et al</italic>, 2020</xref>; <xref ref-type="bibr" rid="R45">Wrapp <italic>et al</italic>, 2020</xref>). However, a third prefusion conformation, called “locked”, was subsequently identified in multiple studies using either full-length spikes or spike ectodomains (<xref ref-type="bibr" rid="R2">Bangaru <italic>et al</italic>, 2020</xref>; <xref ref-type="bibr" rid="R3">Cai <italic>et al</italic>, 2020</xref>; <xref ref-type="bibr" rid="R37">Toelzer <italic>et al</italic>, 2020</xref>; <xref ref-type="bibr" rid="R47">Wrobel <italic>et al</italic>, 2020</xref>; <xref ref-type="bibr" rid="R48">Xiong <italic>et al</italic>, 2020</xref>). In pH neutral phosphate buffered saline (PBS), this conformation appeared to be transient and only a small fraction of purified spikes adopted locked conformations (<xref ref-type="bibr" rid="R48">Xiong <italic>et al.</italic>, 2020</xref>). Overall, locked conformations are more ordered, adopting a more tightly packed trimeric quaternary structure, possessing features including, bound lipid in RBD, rigidified Domain D region and ordered fusion peptide proximal region (FPPR, residues 833-855 in SARS-CoV-2 S).</p><p id="P5">Detailed structural analysis of SARS-CoV-2 S structures identified that interactions between Domain D and Domain C-D hinge region in locked conformations likely restrain RBD movement leading to more compact spike packing (<xref ref-type="bibr" rid="R30">Qu <italic>et al</italic>, 2022</xref>). A comparison to other CoV S structures revealed that HCoV-NL63 (<xref ref-type="bibr" rid="R42">Walls <italic>et al.</italic>, 2016b</xref>), MHV (<xref ref-type="bibr" rid="R41">Walls <italic>et al.</italic>, 2016a</xref>), Infectious Bronchitis Virus (IBV) (<xref ref-type="bibr" rid="R34">Shang <italic>et al</italic>, 2018</xref>) and Porcine Delta coronavirus (PDCoV) (<xref ref-type="bibr" rid="R49">Xiong <italic>et al</italic>, 2018</xref>) spikes are structurally more related to locked structures of SARS-CoV-2 spike, they all have ordered FPPR which is incompatible with RBD in “up” position (<xref ref-type="bibr" rid="R48">Xiong <italic>et al.</italic>, 2020</xref>). More perplexingly, locked conformations were not observed for spikes on fixed SARS-CoV-2 virus particles (<xref ref-type="bibr" rid="R17">Ke et al, 2020</xref>; <xref ref-type="bibr" rid="R39">Turoňová et al, 2020</xref>; <xref ref-type="bibr" rid="R50">Yao et al, 2020</xref>).</p><p id="P6">We and others engineered disulfide bonds to trap SARS-CoV-2 spike in RBD “down” conformations (<xref ref-type="bibr" rid="R16">Henderson <italic>et al</italic>, 2020</xref>; <xref ref-type="bibr" rid="R25">McCallum <italic>et al</italic>, 2020</xref>; <xref ref-type="bibr" rid="R48">Xiong <italic>et al.</italic>, 2020</xref>). In addition to increased spike stability, we found that x1 (<xref ref-type="bibr" rid="R48">Xiong <italic>et al.</italic>, 2020</xref>) and x3 (<xref ref-type="bibr" rid="R30">Qu <italic>et al.</italic>, 2022</xref>) disulfide bonds increase proportions of purified spikes adopting locked conformations. Structural studies of x3 disulfide stabilized locked spikes allowed us to further classify locked spikes into “locked-1” and “locked-2” conformations, which differ primarily in ways how Domain D region rigidifies. Protomers in a SARS-CoV-2 S trimer can adopt exclusively “locked-1” or “locked-2” conformations or a trimer can be formed by protomers of the two locked conformations in various combinations (<xref ref-type="bibr" rid="R30">Qu <italic>et al.</italic>, 2022</xref>). Together with “closed” and “open” conformations, prefusion SARS-CoV-2 spike exhibits complex dynamics.</p><p id="P7">Despite considerable sequence homology to SARS-CoV-2 S, currently determined structures of SARS-CoV-1 spikes are either in closed or open conformation (<xref ref-type="bibr" rid="R13">Gui <italic>et al.</italic>, 2017</xref>; <xref ref-type="bibr" rid="R51">Yuan <italic>et al.</italic>, 2017</xref>). Locked conformations remain elusive for SARS-CoV-1 spike, therefore dynamics of the spike likely remains incompletely characterized. In this study, we engineered SARS-CoV-1 spikes bearing the x1, x2, and x3 disulfides. We purified engineered SARS-CoV-1 spikes and characterized their biochemical properties. By Cryo-EM, engineered SARS-CoV-1 spikes allowed us to determine a series of spike structures adopting previously undetected conformations. We compared these structures to available spike structures of other Sarbecoviruses to identify conserved features.</p><sec id="S2"><title>Production of SARS-CoV-1 spikes with engineered disulfide bonds</title><p id="P8">x1, x2 and x3 (sites in SARS-CoV-2 S numbering: x1, S383C and D985C; x2, G413C and V987C; x3, D427C and V987C) disulfide bonds were designed for SARS-CoV-2 spike (<xref ref-type="bibr" rid="R30">Qu <italic>et al.</italic>, 2022</xref>; <xref ref-type="bibr" rid="R48">Xiong <italic>et al.</italic>, 2020</xref>). These disulfides facilitate formation of covalently linked spike trimers through the introduced disulfides between RBD and S2 of a neighboring spike protomer. x1 disulfide has been previously introduced in SARS-CoV-1 spike to show successful disulfide formation (<xref ref-type="bibr" rid="R25">McCallum <italic>et al.</italic>, 2020</xref>). We introduced these three disulfide bonds in equivalent positions in the SARS-CoV-1 S sequence generating three spike variants: S/x1 (S370C and D967C), S/x2 (G400C and V969C) and S/x3 (D414C and V969C) (<xref ref-type="fig" rid="F1">Fig. 1a</xref> and <xref ref-type="supplementary-material" rid="SD1">Fig. S1</xref>). These spike variants were expressed in Expi293 cells to be secreted into culture media. Compared to purified unmodified SARS-CoV-1 spike ectodomain, purified S/x1, S/x2 and S/x3 SARS-CoV-1 spikes successfully form covalently linked trimers in SDS-PAGE under non-reducing conditions and these trimers could be reduced to monomers under denaturing conditions (<xref ref-type="fig" rid="F1">Fig. 1b</xref> <bold>and</bold> <xref ref-type="supplementary-material" rid="SD1">Fig. S2</xref>). x1, x2, and x3 disulfides in SARS-CoV-1 spike exhibit different sensitivity to reducing agent. Under native conditions, x2 disulfide is more resistant to reduction by DTT than x1 and x3 disulfides, likely reflecting different local chemical environments for different disulfides (<xref ref-type="supplementary-material" rid="SD1">Fig. S2</xref>). Resistance to DTT reduction was also observed for x2 disulfide in SARS-CoV-2 spike (<xref ref-type="bibr" rid="R30">Qu <italic>et al.</italic>, 2022</xref>). Negative-staining EM of purified spike variants showed that S/x1, S/x2 and S/x3 spikes form trimers with morphologies indistinguishable to unmodified SARS-CoV-1 spike ectodomain (S/native) (<xref ref-type="fig" rid="F1">Fig. 1c</xref>). These results confirmed that x1, x2 and x3 disulfides previously designed for SARS-CoV-2 spike are compatible with production of well-formed covalently linked SARS-CoV-1 spike trimers.</p></sec><sec id="S3"><title>Antigenic and immunogenic properties of engineered spikes</title><p id="P9">Purified S/x3 spike was used to immunize mice employing a prime-boost immunization strategy. S/x3 was found to exclusively adopt an RBD “down” locked-1 conformation by cryo-EM (<xref ref-type="fig" rid="F2">Fig. 2h</xref>). After priming by 10 μg of S/x3 spike, mouse sera showed induction of neutralization titers against SARS-CoV-1 pseudovirus (<xref ref-type="fig" rid="F1">Fig. 1d</xref>). Boost by another dose of 10 μg of S/x3 spike, increased neutralization titer further by approximately 100-fold (<xref ref-type="fig" rid="F1">Fig. 1d</xref>). The complete immunization regimen induced a serum neutralization titer of approximately 5 log<sub>10</sub> dilution units (<xref ref-type="fig" rid="F1">Fig. 1d</xref>). We found mouse immune sera raised with engineered SARS-CoV-2 RBD “down” S-R/x2 (“-R” stands for furin site changed to a single “arginine” and “x2” stands for the introduced x2 disulfide) spike protein as the immunogen gave similar neutralization titers (<xref ref-type="bibr" rid="R4">Carnell <italic>et al</italic>, 2021</xref>). By ELISA (enzyme-linked immunosorbent assay), the S/x3 induced immune sera exhibit binding towards SARS-CoV-1 S/native, S/x1, S/x2, and S/x3 spikes. There are differences in reactivity of S/x3 immune sera towards different spikes, but the differences are not statistically significant (<xref ref-type="fig" rid="F1">Fig. 1e</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig. S3a</xref>). SARS-CoV-2 S-GSAS/6P immune sera cross-react with S/native, S/x1, S/x2, and S/x3 spikes, and as expected, it showed reduced reactivity compared to S/x3 immune sera (<xref ref-type="fig" rid="F1">Fig. 1f</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig. S3b</xref>).</p></sec><sec id="S4"><title>SARS-CoV-1 spikes with engineered disulfide bonds reveal additional conformations</title><p id="P10">We determined cryo-EM structures of SARS-CoV-1 S/x1, S/x2 and S/x3 spikes and we identified various previously undetected conformations for SARS-CoV-1 S through classification procedures (see <xref ref-type="supplementary-material" rid="SD1">Fig. S4</xref>). SARS-CoV-1 S/x1 spike exhibited complex dynamics, we observed spikes adopting both symmetrical and asymmetrical conformations. Symmetrical locked-1 (3 locked-1 protomers) and symmetrical locked-2 (3 locked-2 protomers) spike trimers differ at Domain D-loop (residues 602-627) and FPPR structures (<xref ref-type="fig" rid="F2">Fig. 2a, b</xref> and <xref ref-type="fig" rid="F3">Fig. 3a, b</xref>). In addition, we observed asymmetrical locked-112 (2 locked-1 protomers and 1 locked-2 protomer, <xref ref-type="fig" rid="F2">Fig. 2c</xref>) and locked-122 (1 locked-1 protomer and 2 locked-2 protomers, <xref ref-type="fig" rid="F2">Fig. 2d</xref>) spike trimers. Similar structural heterogeneity has been observed for the SARS-CoV-2 S-R/x3 spike in various locked conformations (<xref ref-type="bibr" rid="R30">Qu <italic>et al.</italic>, 2022</xref>). Interestingly, SARS-CoV-1 S/x1 spike also adopts an asymmetrical closed conformation: FPPR in one protomer adopts an ordered extruding conformation while being disordered in the other two protomers (<xref ref-type="fig" rid="F2">Fig. 2e</xref>, <xref ref-type="fig" rid="F3">Fig. 3d</xref>). By cryo-EM, only symmetrical spike trimers were observed for SARS-CoV-1 S/x2 and S/x3 spikes. S/x2 spike adopts symmetrical locked-2 (<xref ref-type="fig" rid="F2">Fig. 2f</xref> and <xref ref-type="fig" rid="F3">Fig. 3c</xref>) and closed (<xref ref-type="fig" rid="F2">Fig. 2g</xref> and <xref ref-type="supplementary-material" rid="SD1">Fig. S5a</xref>) conformations. S/x3 spike was only observed to adopt a symmetrical locked-1 conformation (<xref ref-type="fig" rid="F2">Fig. 2h</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig. S5b</xref>). Overall, locked-1, locked-2 are structurally more rigid than closed conformations showing tighter packing and less flexibility towards RBD end of spike (<xref ref-type="supplementary-material" rid="SD1">Fig. S6</xref> <bold>and</bold> <xref ref-type="supplementary-material" rid="SD1">Fig. S7</xref>). Structures within each identified conformation categories, namely locked-1, locked-2 and closed, share almost identical structural features. Between different conformation categories, there are variations in structures of Domain D, FPPR and positioning of RBD. These variations appear to result different spike trimer packing (<xref ref-type="supplementary-material" rid="SD1">Fig. S7</xref>). Distinct structures from different conformation categories are summarized and described in details in the next sections.</p></sec><sec id="S5"><title>Structural features of SARS-CoV-1 spikes in different conformations</title><p id="P11">To further understand conformational dynamics of SARS-CoV-1 spike, representative structures in each conformation category are summarized in <xref ref-type="fig" rid="F3">Fig. 3</xref> with features highlighted (additional structures are shown <xref ref-type="supplementary-material" rid="SD1">Fig. S5</xref>). In SARS-CoV-1 S/x1 locked-1 protomers (<xref ref-type="fig" rid="F3">Fig. 3a</xref>), a linoleic acid can be modelled in the density identified in a lipid binding pocket within the RBD. This pocket was previously identified in SARS-CoV-2 spike and it has been proposed to be a conserved feature in betacoronavirus spikes (<xref ref-type="bibr" rid="R37">Toelzer <italic>et al.</italic>, 2020</xref>). By cryo-EM, we confirmed that the lipid is bound in a highly conserved fashion between SARS-CoV-1 and SARS-CoV-2 spikes. The aliphatic tail of the bound lipid is surrounded by aromatic amino acids lining the pocket. The pocket is gated by a small helix from a neighboring protomer to allow R395 within the gating helix to form salt bridge to the negatively charged lipid head group (<xref ref-type="fig" rid="F3">Fig. 3a</xref>, <bold>right panel</bold>). Therefore, the bound lipid is interacting with RBDs of two neighboring protomers and these interactions are consistent to the proposal that they stabilize locked conformations (<xref ref-type="bibr" rid="R37">Toelzer <italic>et al.</italic>, 2020</xref>). In the S/x1 locked-1 protomer, cryo-EM density for residues between 602 and 619 is not visible suggesting that these residues form a flexible loop (<xref ref-type="fig" rid="F3">Fig. 3a</xref>, <bold>left panel</bold> and <xref ref-type="fig" rid="F4">Fig. 4a</xref>). In an unusual dimer of locked-1 conformation SARS-CoV-2 spikes, formation of a large extended loop by this region was confirmed (<xref ref-type="bibr" rid="R2">Bangaru <italic>et al.</italic>, 2020</xref>). In S/x1 locked-2 spike protomers (<xref ref-type="fig" rid="F3">Fig. 3b</xref>), linoleic acid is bound in the RBD in an almost identical way as observed for the locked-1 protomer (<xref ref-type="fig" rid="F3">Fig. 3b</xref>, <bold>right panel</bold>). Different from locked-1 spike protomers, residues between 602 and 619 in S/x1 locked-2 spike protomers refold into ordered structures showing clear cryo-EM density (<xref ref-type="fig" rid="F3">Fig. 3b</xref>, <bold>left panel</bold> and <xref ref-type="fig" rid="F4">Fig. 4b</xref>). The S/x2 locked-2 spike protomer displays cryo-EM density showing an ordered 602-619 region in Domain D (<xref ref-type="fig" rid="F3">Fig. 3c</xref>, <bold>left panel</bold>), highly similar to S/x1 locked-2 spike protomer (<xref ref-type="fig" rid="F3">Fig. 3b</xref>, <bold>left panel</bold>). Surprisingly, the lipid binding pocket is unoccupied even though the entrance to the pocket is closed by the gating helix (<xref ref-type="fig" rid="F3">Fig. 3c</xref>, <bold>right panel</bold>). S/x3 spike was only observed to adopt a symmetrical locked-1 conformation, its protomers share very similar features as S/x1 locked-1 protomers, with bound lipid and residues 602-619 forming a flexible loop (<xref ref-type="supplementary-material" rid="SD1">Fig. S5b</xref>).</p><p id="P12">We identified clear densities consistent to biliverdin molecules in S/x1 locked-1, locked-2, locked-112 and locked-122 structures in a NTD pocket equivalent to the previously identified biliverdin binding pocket in SARS-CoV-2 S (<xref ref-type="bibr" rid="R30">Qu <italic>et al.</italic>, 2022</xref>; <xref ref-type="bibr" rid="R32">Rosa <italic>et al</italic>, 2021</xref>) (<xref ref-type="supplementary-material" rid="SD1">Fig. S5c</xref>). Despite imaged under similar conditions, no density or very weak densities for biliverdin were observed in the biliverdin binding pockets of the other currently reported structures. In contrast, biliverdin densities were evident in spikes of locked and closed conformations for SARS-CoV-2 (<xref ref-type="bibr" rid="R30">Qu <italic>et al.</italic>, 2022</xref>). We noticed certain degrees of sequence conservation within the largely hydrophobic biliverdin binding pocket between SARS-CoV-1 and SARS-CoV-2 S, but there are changes at several interacting residues (<xref ref-type="supplementary-material" rid="SD1">Fig. S5c</xref>). Molecular simulations suggested sequence changes in this pocket could affect biliverdin binding (<xref ref-type="bibr" rid="R31">Qu <italic>et al</italic>, 2021</xref>). It has been suggested that biliverdin binding could interfere with antibody binding (<xref ref-type="bibr" rid="R6">Cerutti <italic>et al</italic>, 2021</xref>; <xref ref-type="bibr" rid="R32">Rosa <italic>et al.</italic>, 2021</xref>). Spike NTD has been previously observed to bind cofactors with unknown functions with regard to CoV life cycle, for example, folic acid has been identified to bind MERS-CoV spike NTD (<xref ref-type="bibr" rid="R27">Pallesen <italic>et al</italic>, 2017</xref>). SARS-CoV-1 and SARS-CoV-2 represent two distinct lineages of Sarbecoviruses (<xref ref-type="bibr" rid="R14">Guo <italic>et al</italic>, 2021</xref>), conservation of biliverdin binding pocket between their spikes, may suggest an unidentified physiological role for this molecule in Sarbecoviruses infection cycle.</p><p id="P13">Two distinct conformations were identified for protomers in the closed S/x1 asymmetrical spike (<xref ref-type="fig" rid="F3">Fig. 3d and e</xref>). In both conformations, lipid binding pockets were unoccupied, consistent to the fact that the gating helices from neighboring protomers are dislocated leaving lipid binding pockets open (<xref ref-type="fig" rid="F3">Fig. 3d and e</xref>, <bold>right panels</bold>). In both closed protomers, clear cryo-EM densities were observed for residues between 602 and 619 (<xref ref-type="fig" rid="F3">Fig. 3d and e</xref>, <bold>left panels and</bold> <xref ref-type="fig" rid="F4">Fig. 4c and d</xref>). However, they adopted a different structure comparing to the equivalent region in the locked-2 protomers (compared to <xref ref-type="fig" rid="F3">Fig. 3b and c</xref>, <bold>left panels</bold>). FPPR has been found disordered in closed SARS-CoV-2 spikes, in line with this observation, FPPR is disordered in 2 of the 3 protomers within the SARS-CoV-1 S/x1 asymmetrical closed spike. However, surprisingly, one of the protomer has an FPPR forming an ordered extruding structure (<xref ref-type="fig" rid="F3">Fig. 3d</xref>, <bold>left panel)</bold>. S/x2 spike can adopt a symmetrical closed conformation, spike protomer of this conformation has empty lipid binding pocket and disordered FPPR (<xref ref-type="supplementary-material" rid="SD1">Fig. S5a</xref>). Therefore, S/x2 closed protomer has almost identical features to the S/x1 closed protomer with a disordered FPPR (compare <xref ref-type="supplementary-material" rid="SD1">Fig. S5a</xref> and <xref ref-type="fig" rid="F3">Fig. 3e</xref>).</p></sec><sec id="S6"><title>Domain D adopts different structures in SARS-CoV-1 spikes of different conformations</title><p id="P14">We summarized four representative structural arrangements around Domain D identified from determined cryo-EM structures. We examined interactions around Domain D in these structures in details. In locked-1 protomers, interdigitation interactions between Y622, F305, R620, and Y819 are formed through π-π and cation-π interactions (<xref ref-type="fig" rid="F4">Fig. 4a</xref>). These interactions connect structural elements of Domain D (Y622, R620), Domain C-D hinge region (F305) and FPPR (F819) (<xref ref-type="fig" rid="F4">Fig. 4a</xref>). Equivalent interdigitation interactions were observed in SARS-CoV-2 locked-1 spike. We have proposed that these interactions rigidify this area preventing structural transitions needed for RBD opening (<xref ref-type="bibr" rid="R30">Qu <italic>et al.</italic>, 2022</xref>). Density for residues 602-619 is not visible and the equivalent region is known to form a large disordered loop in SARS-CoV-2 S adopting a locked-1 conformation (<xref ref-type="bibr" rid="R2">Bangaru <italic>et al.</italic>, 2020</xref>) (<xref ref-type="fig" rid="F4">Fig. 4a</xref>). Hydrophobic residues W619, I621 located at C-terminus of the loop interact with V596, Y598, and I637 of Domain D hydrophobic core (<xref ref-type="fig" rid="F4">Fig. 4a</xref>). Both the interdigitation and hydrophobic interactions appear to hold the disordered loop in place. A salt bridge is formed between D600 of Domain D and K836 of FPPR (<xref ref-type="fig" rid="F4">Fig. 4a</xref>). D600 is equivalent to D614 in SARS-CoV-2 spike and D614G is the earliest mutation became fixed in SARS-CoV-2 spike since the pandemic and all subsequent variants bear this mutation (<xref ref-type="bibr" rid="R12">Grubaugh <italic>et al</italic>, 2020</xref>; <xref ref-type="bibr" rid="R21">Korber <italic>et al</italic>, 2020</xref>). Likely stabilized by the participated interactions, FPPR is ordered in locked-1 conformation consisting of two small helices connected by a disulfide between C822-C833 (<xref ref-type="fig" rid="F4">Fig. 4a</xref>). Presence of this structural motif is known to be incompatible with RBD in “up” position (<xref ref-type="bibr" rid="R48">Xiong <italic>et al.</italic>, 2020</xref>).</p><p id="P15">In the locked-2 conformation, the highly dynamic region between residues 602-627 in Domain D (Domain D-loop) undergoes drastic refolding (<xref ref-type="fig" rid="F4">Fig. 4b</xref>) to adopt a fully ordered “Domain D-loop conformation-1” with several mini-helices within the loop. Interdigitation interactions connecting Domain D, Domain C-D hinge region and FPPR in the locked-1 conformation are broken. Residues between 602 and 619 become ordered in the locked-2 conformation (<xref ref-type="fig" rid="F4">Fig. 4b</xref>). A change of Domain C-D hinge region structure allows residues R306 and F578 to interact with W619 and Domain D hydrophobic core by cation-π and hydrophobic interactions, respectively. These interactions likely still rigidify this region to maintain the more tightly packed locked-2 conformation (<xref ref-type="supplementary-material" rid="SD1">Fig. S6</xref> and <xref ref-type="supplementary-material" rid="SD1">Fig. S7</xref>). Most interactions between FPPR and other parts of spike, including the interdigitation interactions are lost, only the salt-bridge between K836 of FPPR and D600 of Domain D is retained. FPPR is partially ordered with clear density only for the helix formed by residues 830-838 (<xref ref-type="fig" rid="F4">Fig. 4b</xref> and <xref ref-type="fig" rid="F3">Fig. 3b, c</xref>).</p><p id="P16">Further structural changes around Domain D occur in the S/x1 closed conformations, a large structural change caused bending and rotation of Domain C-D hinge region allowing residue F305 to interact with the Domain D hydrophobic core (<xref ref-type="fig" rid="F4">Fig. 4c and d</xref>). The large Domain D-loop (residues 602-627) assumes a different ordered conformation (here we refer it as “Domain D-loop conformation-2”), the three mini-helices in Domain D-loop of locked-2 conformation unfold and a longer helix between 602-610 is formed (<xref ref-type="fig" rid="F4">Fig. 4c and d</xref>). This conformational change allowed R620 to interact with NTD F62 mainchain carbonyl and D277 sidechain carboxylate by hydrogen bond and salt bridge respectively (<xref ref-type="fig" rid="F4">Fig. 4c and d</xref>). Due to this refolding, W619 and Y622 interact with the Domain D hydrophobic core differently (<xref ref-type="fig" rid="F4">Fig. 4c and d</xref>). While the above described interactions involve residues conserved between SARS-CoV-1 and SARS-CoV-2 spikes, cryo-EM density was not observed for Domain D-loop in SARS-CoV-2 spike of closed conformation, suggesting that the equivalent Domain D-loop adopts a different flexible conformation (<xref ref-type="bibr" rid="R30">Qu <italic>et al.</italic>, 2022</xref>). We identified numerous residues in or around Domain D differ between SARS-CoV-1 and SARS-CoV-2 spikes (<xref ref-type="supplementary-material" rid="SD1">Fig. S8</xref>) making it difficult to pin down which amino acid changes result in different Domain D structural dynamics between the two spikes. We noted though, if T260 in SARS-CoV-1 S is substituted for an arginine found in the equivalent position of SARS-CoV-2 S (<xref ref-type="fig" rid="F4">Fig. 4c-d</xref> and <xref ref-type="supplementary-material" rid="SD1">Fig. S8</xref>), it would be in close proximity to R620 of Domain D-loop, repulsion between the two positively charged residues would be unfavorable for Domain D-loop to adopt the ordered “Domain D-loop conformation-2” that is featured in closed conformations of SARS-CoV-1 spike.</p></sec><sec id="S7"><title>SARS-CoV-1 and SARS-CoV-2 spikes sample similar conformations</title><p id="P17">Previously we found domain movement in a protomer alters trimer packing resulting in differences in spike quaternary structure between locked and closed conformations (<xref ref-type="bibr" rid="R30">Qu <italic>et al.</italic>, 2022</xref>). To further understand conformational dynamics of SARS-CoV-1 spike, S1 of SARS-CoV-1 spikes of different conformations were structurally aligned using Domain D as the reference (<xref ref-type="fig" rid="F5">Fig.5</xref> and <xref ref-type="supplementary-material" rid="SD1">Fig. S9</xref>). The overlaps show that drastic refolding of Domain D between locked-1 and locked-2 conformations alters the structure of Domain C-D hinge region and affects the structure of FPPR (<xref ref-type="fig" rid="F5">Fig. 5a</xref>). Despite these extensive structural changes, positioning of NTD and RBD is largely unaffected, only small shifts in NTD and RBD positions are observed (<xref ref-type="fig" rid="F5">Fig. 5a</xref>). Similarly, the two closed conformations are almost superimposable when aligned, despite structural differences in FPPR (<xref ref-type="fig" rid="F5">Fig. 5b</xref>). In contrast, comparison of SARS-CoV-1 S locked-1 and locked-2 conformations to closed conformations revealed that positioning of RBD differ considerably between locked and closed conformations (<xref ref-type="fig" rid="F5">Fig. 5c and d</xref>). The overlap of locked and closed conformations revealed that RBD movement originates from the bendings in the Domain C-D hinge region (<xref ref-type="fig" rid="F5">Fig. 5c and d</xref>). We previously also identified similar characteristics for SARS-CoV-2 S, structural transition from locked conformations to closed conformation is associated with refolding of Domain D, bending of Domain C-D hinge region, and movement of RBD (<xref ref-type="bibr" rid="R30">Qu <italic>et al.</italic>, 2022</xref>). Overlaps of SARS-CoV-1 and SARS-CoV-2 S1 of different conformations reveal that spikes of the two CoVs share very similar locked-1, locked-2 and closed conformations (<xref ref-type="fig" rid="F5">Fig. 5e-g</xref>).</p><p id="P18">Several details are different: first, whilst FPPR is fully ordered in SARS-CoV-2 S of both locked-1 and locked-2 conformations (<xref ref-type="fig" rid="F5">Fig. 5e and f</xref>), FPPR is only fully ordered in SARS-CoV-1 S of locked-1 conformation (<xref ref-type="fig" rid="F5">Fig. 5e</xref>). Second, SARS-CoV-2 S in closed conformation is characterized by its disordered Domain D-loop and FPPR (<xref ref-type="fig" rid="F5">Fig. 5g</xref>), whereas in SARS-CoV-1 S, Domain D-loop is refolded to adopt an ordered structure but distinct from that in locked-2 conformation (<xref ref-type="fig" rid="F5">Fig. 5g</xref> and <xref ref-type="fig" rid="F4">Fig. 4b, c, d</xref>). Third, we identified an asymmetrical closed conformation for SARS-CoV-1 S in which FPPR is dynamic adopting either extruding loop or disordered structures, whereas FPPR is usually fully disordered in closed conformation SARS-CoV-2 S (<xref ref-type="fig" rid="F5">Fig. 5b</xref>). Previously, dynamics was observed for FPPR when SARS-CoV-2 spike was treated with acidic pH (<xref ref-type="fig" rid="F5">Fig. 5h</xref>) (<xref ref-type="bibr" rid="R57">Zhou <italic>et al</italic>, 2020</xref>).</p></sec></sec><sec id="S8" sec-type="discussion"><title>Discussion</title><p id="P19">Class I viral membrane fusion glycoproteins are evolved to have metastable prefusion conformation (<xref ref-type="bibr" rid="R15">Harrison, 2008</xref>). Introduction of disulfides into viral fusogenic glycoproteins has been proven useful to stabilize flu HA (<xref ref-type="bibr" rid="R11">Godley <italic>et al</italic>, 1992</xref>; <xref ref-type="bibr" rid="R23">Lee <italic>et al</italic>, 2015</xref>), HIV GP160 (<xref ref-type="bibr" rid="R33">Sanders <italic>et al</italic>, 2013</xref>) and paramyxovirus F proteins (<xref ref-type="bibr" rid="R26">McLellan <italic>et al</italic>, 2013</xref>; <xref ref-type="bibr" rid="R44">Wong <italic>et al</italic>, 2016</xref>) in various prefusion conformations for mechanistic, structural and vaccinology studies. Here, we introduced x1, x2, x3 disulfides previously designed for SARS-CoV-2 S into SARS-CoV-1 S, this allowed structural characterization of previously unobserved conformations for SARS-CoV-1 spike. Newly determined structures revealed that SARS-CoV-1 S is able to form symmetrical locked-1, locked-2 trimers or asymmetrical trimers made up by locked-1 and locked-2 protomers in various combinations. An asymmetrical closed trimer was also observed with one of the protomer featuring an extruding FPPR. Therefore, together with previously determined structures, it is confirmed that SARS-CoV-1 spike can adopt locked-1, locked-2, closed and RBD “up” open conformations. SARS-CoV-1 and SARS-CoV-2 spikes appear to sample similar conformations and they both exhibit complex conformational dynamics.</p><p id="P20">Structures of a few other Sarbecovirus spikes have also been determined. SARSr-CoV spikes, namely Guangdong (GD) pangolin-CoV S (<xref ref-type="bibr" rid="R46">Wrobel <italic>et al</italic>, 2021</xref>), Guangxi (GX) pangolin-CoV S (<xref ref-type="bibr" rid="R54">Zhang <italic>et al</italic>, 2021b</xref>), and RaTG13 bat-CoV (<xref ref-type="bibr" rid="R47">Wrobel <italic>et al.</italic>, 2020</xref>; <xref ref-type="bibr" rid="R54">Zhang <italic>et al.</italic>, 2021b</xref>) S, only adopt the locked-2 conformation, when imaged by cryo-EM (<xref ref-type="fig" rid="F5">Fig. 5i-l</xref>). Therefore, SARSr-CoV spikes are different from SARS-CoV-1 and SARS-CoV-2 spikes exhibiting reduced structural dynamics. Alternatively, closed/open conformations of SARSr-CoV spikes may not be stable enough to withstand cryo-EM sample preparation procedures and that the more structurally rigid spikes in locked conformations were preferentially imaged.</p><p id="P21">For SARS-CoV-2 (<xref ref-type="bibr" rid="R37">Toelzer <italic>et al.</italic>, 2020</xref>) and SARSr-CoV spikes (<xref ref-type="bibr" rid="R54">Zhang <italic>et al.</italic>, 2021b</xref>), locked conformations are often associated with lipid binding in RBD and lipid binding has been proposed to stabilize locked spike trimers (<xref ref-type="bibr" rid="R37">Toelzer <italic>et al.</italic>, 2020</xref>). In this study, association of lipid binding and locked conformations was observed for SARS-CoV-1 S/x1 and S/x3 spikes. Previously, we and others found that low-pH was able to convert closed/open SARS-CoV-2 spike to locked conformations (<xref ref-type="bibr" rid="R30">Qu <italic>et al.</italic>, 2022</xref>; <xref ref-type="bibr" rid="R57">Zhou <italic>et al.</italic>, 2020</xref>). Based on these observations and the egress pathway characterized for betacoronaviruses (<xref ref-type="bibr" rid="R10">Ghosh <italic>et al</italic>, 2020</xref>), we have proposed that locked conformations are associated with virus particle assembly in low-pH, lipid rich endomembrane structures (<xref ref-type="bibr" rid="R30">Qu <italic>et al.</italic>, 2022</xref>).</p><p id="P22">In this study we confirmed that locked-1 and locked-2 conformations are shared between SARS-CoV-1 and SARS-CoV-2 spikes and locked-2 conformations are shared among all characterized Sarbecovirus spikes. Structural characterization reveals that, although details differ between locked-1 and locked-2 conformations, restraining RBD movement by interactions between Domain D and Domain C-D hinge region is shared by locked conformations of Sarbecovirus spikes. Conservation of RBD restraining mechanisms in locked conformations among Sarbecovirus spikes suggests locked conformations may play a conserved function in Sarbecovirus life cycle.</p><p id="P23">Previously, only closed and open conformations were observed for purified SARS-CoV-1 S (<xref ref-type="supplementary-material" rid="SD1">Fig. S9g-l</xref>). We have attempted to convert native SARS-CoV-1 S ectodomain (S/native) without engineered disulfide to locked conformation by prolonged incubation under low-pH (pH 5.5 for 24 hr), however, we only observed open and closed spikes after incubation (<xref ref-type="supplementary-material" rid="SD1">Fig. S4</xref>). In line with previously determined SARS-CoV-1 S structures (<xref ref-type="bibr" rid="R13">Gui <italic>et al.</italic>, 2017</xref>; <xref ref-type="bibr" rid="R51">Yuan <italic>et al.</italic>, 2017</xref>), Domain D-loops in closed and open spike structures determined under low-pH are ordered, adopting “Domain D-loop conformation-2”, showing almost identical conformations as previously detailed for the closed conformation (<xref ref-type="supplementary-material" rid="SD1">Fig. S9</xref> and <xref ref-type="supplementary-material" rid="SD1">Fig. S10</xref>). Of note, during preparation of this manuscript, a preprint reported a subpopulation of purified insect cell expressed (presumably expressed in low-pH insect cell media) SARS-CoV-1 spike ectodomain adopted a locked-2 conformation with lipid bound in RBD (<xref ref-type="bibr" rid="R38">Toelzer <italic>et al</italic>, 2022</xref>). We speculate that unlike SARS-CoV-2 S, where Domain D-loops are disordered in closed and open conformations, breaking interactions involving the ordered Domain D-loops in closed and open conformations represents a barrier to revert closed/open spike to locked conformations for SARS-CoV-1 S. This difference reflects how changes in Domain D may affect dynamics of Sarbecovirus spikes. Indeed, D614G mutation (<xref ref-type="bibr" rid="R52">Yurkovetskiy <italic>et al</italic>, 2020</xref>; <xref ref-type="bibr" rid="R53">Zhang <italic>et al</italic>, 2021a</xref>) and proteolytic cleavage by cathepsin L (<xref ref-type="bibr" rid="R55">Zhao <italic>et al</italic>, 2022</xref>), both within Domain D, are known to affect dynamics of SARS-CoV-2 spike.</p><p id="P24">In summary, SARS-CoV-1 and SARS-CoV-2 spikes exhibit complex conformational dynamics among Sarbecovirus spikes. Biological functions of these different conformations remain to be further confirmed or elucidated. In addition, underlying mechanisms by which different Sarbecovirus spikes sample various conformations differently and the associated biological consequences remain poorly understood. Future “<italic>in-situ</italic>” structural studies under more conditions may provide further clues for these questions. Nevertheless, in this study, we demonstrated that introduction of stabilizing disulfides in SARS-CoV-1 spike is useful for capturing otherwise transient conformations allowing more thorough characterization of spike dynamics. We further demonstrated engineered S/x3 spike as an immunogen. Together with previously determined SARS-CoV-2 spike structures, we believe conserved features characterized for SARS-CoV-1 and SARS-CoV-2 spikes should help further understanding of Sarbecovirus spike function.</p></sec><sec id="S9" sec-type="materials | methods"><title>Materials and Methods</title><sec id="S10"><title>Protein expression and purification</title><p id="P25">S/native construct was generated by cloning S gene of SARS-CoV-1 (SARS coronavirus Tor2, NCBI:txid227984) between amino acid residues 15-1193 into a modified pcDNA3.1 vector previously described (<xref ref-type="bibr" rid="R43">Walls <italic>et al</italic>, 2019</xref>; <xref ref-type="bibr" rid="R48">Xiong <italic>et al.</italic>, 2020</xref>). The S/native construct encodes an exogenous N-terminal signal peptide MGILPSPGMPALLSLVSLLSVLLMGCVAETGT derived from μ-phosphatase and a C-terminal extension GSGR<italic>ENLYFQ</italic>GGG<underline>GSGYIPEAPRDGQAYVRKDGEWVLLSTFL</underline>G<bold>HHHH HH</bold>. The C-terminal extension contains a tobacco etch virus (TEV) protease cleavage site (italic), a T4 trimerization foldon (underlined) and a hexa-Histidine-tag (bold). This construct is called S/native. S/x1 (S370C and D967C), S/x2 (G400C and V969C) and S/x3 (D414C and V969C) containing the introduced cysteines were generated by PCR.</p><p id="P26">Spike proteins were expressed by transient transfection in Expi293 cells, 1 mg of DNA was transfected into 1 L of cells using PEI transfection reagent. After transfection, cells were cultured at 33 °C for 5 days. Supernatants were harvested by centrifugation and 25 mM phosphate pH 8.0, 5 mM imidazole, 300 mM NaCl were supplemented. Supernatant was recirculated onto a 5-ml Talon Cobalt column for ~2.5 times and the column was washed by 100 ml buffer A (25 mM phosphate pH 8.0, 5 mM imidazole, 300 mM NaCl). Spike protein was eluted by a linear gradient using increasing concentration of Buffer B (25 mM phosphate pH 8.0, 500 mM imidazole, 300 mM NaCl). Purified spike proteins were quality checked by SDS-PAGE and buffered exchanged into PBS and frozen at -80 °C until further use.</p></sec><sec id="S11"><title>Negative-staining EM</title><p id="P27">Spike proteins were diluted to 0.06 mg/ml and 3μl samples were applied onto glow-discharged (15 mA, 45 s glow) carbon-coated copper grids. Protein samples were absorbed for 1 minute, before grids were washed with water once. Samples were stained twice with 0.75% (w/v) uranyl formate solution. Grids were air dried and imaged in an FEI Tecnai G2 Spirit transmission electron microscope operating at 120 keV equipped with a CCD camera.</p></sec><sec id="S12"><title>Disulfide bond reduction under native conditions</title><p id="P28">S/x1, S/x2, and S/x3 spike proteins were incubated with 0, 2.5, 5, 10, and 20 mM DTT for 5 min or 60 min at room temperature in PBS. Reactions were quenched by addition of 55 mM iodoacetic acid (IAA) for 10 min in the dark at room temperature. Reaction mixtures were mixed with 4× non-reducing loading buffer and were analysed by SDS-PAGE.</p></sec><sec id="S13"><title>Animal Immunization</title><p id="P29">6- to 8-week-old BALB/c females were immunized intramuscularly with 10 μg of purified protein mixed with 100 μg of Sigma Adjuvant System (SAS) in a total volume of 100 μl of PBS. After a 4-week interval, mice were boosted with the same antigen in the same formulation. Day 28 after the priming immunization and day 7 after boost immunization, sera were collected from immunized mice to detect the antigen-specific humoral response by ELISA and pseudovirus neutralization assay.</p></sec><sec id="S14"><title>Pseudovirus neutralization assay</title><p id="P30">Pseudotyped lentiviruses were produced in 293T cells as previously described (<xref ref-type="bibr" rid="R9">Feng <italic>et al</italic>, 2020</xref>) by co-transfecting a plasmid expressing SARS-CoV-1 S protein, a packaging vector and a reporter vector carrying an expression cassette of firefly luciferase. The 4× serially diluted heat-inactivated (HI)-serum (56 °C for 30 min) were incubated with the SARS-CoV-1 pseudotyped virus at 37 °C for 1 h. The mixture was subsequently incubated with HeLa-ACE2 cells for 72 h. The cells were washed twice with PBS and lysed with lysis buffer before measuring luciferase activity. The neutralization titers were calculated as antibodies dilutions at which the luciferase activity was reduced to 50% of that from the virus-only wells.</p></sec><sec id="S15"><title>ELISA assay to determine antibody binding activity to SARS-CoV-1 spikes</title><p id="P31">96 well assay plates were coated with 100 μl per well of SARS-CoV-1 S/native, S/x1, S/x2, or S/x3 spike proteins at 1 μg/ml in PBS overnight at 4 °C. After standard washing, 10% fetal calf serum (FBS, 200 μl per well) was added to block for 2 hours at 37 °C. After washing wells three times with PBS-0.1% Tween 20 (MP Biomedicals), 100 μl semilogarithmic dilutions of antisera in PBS were added to each well and incubated for 2 hours at 37°C. After washing wells 3 times with PBS-0.1% Tween 20, plates were incubated with 1:10000 dilutions of HRP-labelled Goat Anti-Mouse IgG (H + L) (Jackson ImmunoResearch Laboratories) in 10% FBS for 1 h at 37°C. After washing wells 6 times with PBS-0.1% Tween 20, 100 μl per well of TMB (3,3′,5,5′-tetramethylbenzidine) solution (Merck Millipore) was added and developed for 10 min at room temperature. Reactions were stopped by adding 50 μl 2 M sulphuric acid and OD values at 450 nm were measured in a plate reader.</p></sec><sec id="S16"><title>Cryo-EM sample preparation</title><p id="P32">Immediately before cryo-EM sample preparation, spike samples in PBS (S/x1 at 4.7 mg/ml, S/x2 at 6.5 mg/ml, S/x3 at 2.4 mg/ml, S/native at 6.68 mg/ml) were thawed and TEV protease (2.5 mg/ml in PBS) was added to a 10:1 spike/TEV protease w/w ratio. The mixtures were incubated at room temperature for 1 h before used for grids preparation. For the low-pH S/native spike sample, after the TEV protease incubation, per 9 μl of the protein solution was incubated with 1 μl of 1 M pH 5.5 sodium acetate buffer (giving final pH of 5.54 for the protein solution) overnight at room temperature. Quantifoil R1.2/1.3 copper grids were glow-discharged (15 mA, 30 s) before used for specimen preparation. 3 μl protein solution was mixed with 0.3 μl 1% octyl-glucoside (final concentrations of OG were 0.1%) immediately before applied to grid. Grids were blotted (3s, force 4) and rapidly plunge-frozen in liquid ethane using a Vitrobot (Thermo Fisher Scientific) in 100% humidity at 22 °C. Grids were screen in a Talos Arctica G2 electron microscope (Thermo Fisher Scientific) operated by EM facility of Guangzhou Institutes of Biomedicine and Health. Suitable grids with clear side- and top-views of spikes were identified and datasets were collected in the Talos Arctica G2 electron microscope, or a Titan Krios G3i electron microscope (Thermo Fisher Scientific) operated by EM center of Southern University of Science and Technology (SUSTech), Shenzhen.</p></sec><sec id="S17"><title>Cryo-EM data collection</title><p id="P33">The Talos Arctica electron microscope was operating at 200 keV and Serial EM software v3.8.7 was used for data collection. On a K3 direct detection camera (Gatan), micrographs were acquired at a nominal magnification of 45,000×, with a calibrated pixel size of 0.88 Å and a defocus range of -0.8 to -2.5 μm. For the S/x2 and S/x3 samples, each movie was exposed for 1.6 s with a dose rate of 30 e<sup>−</sup>/pixel/second fractionated into 27 frames, resulting a total dose of 62 e<sup>−</sup>/Å<sup>2</sup>. For the low-pH S/native sample, each movie was exposed for 1.8 s with a dose rate of 26 e<sup>−</sup>/pixel/second fractionated into 27 frames, resulting a total dose of 60 e<sup>−</sup>/Å<sup>2</sup>.</p><p id="P34">The Titan Krios G3i electron microscope was operating at 300 keV and EPU software (Thermo Fisher Scientific) was used for data collection. On a BioQuantum K3 direct detection camera (Gatan) using a 20 eV filter slit width operated in zero-loss mode, micrographs were recorded at a nominal magnification of 81,000×, with a calibrated pixel size of 1.095 Å and a defocus range of -0.8 to -2.0 μm. Each movie was exposed for 2.37 s with a dose rate of 25 e<sup>−</sup>/pixel/second, fractionated into 38 frames, resulting a total dose of 50 e<sup>−</sup>/Å<sup>2</sup>.</p></sec><sec id="S18"><title>Cryo-EM data processing</title><p id="P35">Movies were aligned using a MotionCor2-like algorithm (<xref ref-type="bibr" rid="R56">Zheng <italic>et al</italic>, 2017</xref>) implemented in RELION v3.1 (<xref ref-type="bibr" rid="R58">Zivanov <italic>et al</italic>, 2020</xref>), Contrast transfer function (CTF)-estimation and non-templated particle picking were carried out by Warp v1.09 (<xref ref-type="bibr" rid="R36">Tegunov &amp; Cramer, 2019</xref>). 4604239 particles were picked in the S/x1 dataset, 967643 particles were picked in the S/x2 dataset, 82693 particles were picked in the S/x3 dataset, and 1375445 particles were picked in the S/native low-pH dataset. Extracted particles were imported back into RELION. An EM map of SARS-CoV-2 S-R/x2 spike (EMD-11329) (<xref ref-type="bibr" rid="R48">Xiong <italic>et al.</italic>, 2020</xref>) in closed conformation was filtered to 50 Å resolution as the initial model in the first 3D classification of each dataset. Initial 3D classification using the closed spike as initial model was accomplished at bin2 to remove contaminating particles. Particles within 3D classes displaying clear secondary structures were pooled and subjected to cleaning by one round of 2D classification. For the S/native low-pH dataset, micrographs were imported into cryoSPARC (<xref ref-type="bibr" rid="R29">Punjani <italic>et al</italic>, 2017</xref>) to perform blob picking to obtain a template, then 1375445 particles were picked by template picking. One round of 2D classification were followed by the template picking to remove contaminating particles. Selected particles were imported back into RELION to perform an initial 3D classification using a 60 Å filtered closed conformation SARS-CoV-2 S-R/x2 spike map (EMD-11329) as the initial model. Subsequently, a second round of 3D classification using 50 Å filtered closed conformation SARS-CoV-2 S-R/x2 spike map (EMD-11329) was carried out to classify different conformations in each dataset. Auto-refinement, CTF refinement and Bayesian polishing were performed iteratively on classified subsets of different conformations.</p><p id="P36">To classify dynamic features in Domain D region of locked and closed spikes, we used a previously described focused classification method (<xref ref-type="bibr" rid="R30">Qu <italic>et al.</italic>, 2022</xref>) on the S/x1 dataset. Briefly, 576514 and 944224 locked and closed spike particles were symmetry expanded in RELION to obtain 1729542 and 2832672 particles, respectively. A round of in-place 3D classification was carried out using a 30 Å sphere mask around the variable Domain D area using a non-low pass filtered consensus map of the region as the reference. Subsequently, each expanded particle was traced back to its original spike trimer particle. The original trimer particles were classified into locked-1, locked-2, locked-112, locked-122 and an asymmetrical closed conformation with extruding FPPR in one protomer. Those classified classes were subjected to another round of 3D auto-refinement.</p><p id="P37">Following the final round of 3D auto-refinement, map resolutions were estimated by the 0.143 criterion using the phase-randomization-corrected Fourier shell correlation (FSC) curve calculated between two independently refined half-maps multiplied by a soft-edged solvent mask. Final reconstructions were sharpened and locally filtered in RELION. The data processing procedures were summarized in <xref ref-type="supplementary-material" rid="SD1">Fig. S4</xref>. The estimated B-factors of maps are listed in <xref ref-type="supplementary-material" rid="SD1">Table S1</xref>.</p></sec><sec id="S19"><title>Cryo-EM structure model building</title><p id="P38">SARS-CoV-1 spike ectodomain structure (PDB: 5X58) was used as the starting model for building SARS-CoV-1 spike structures of closed conformations. SARS-CoV-2 spike ectodomain structures (PDB: 7XTZ/7XU2) were used as the starting model for building SARS-CoV-1 structures of locked conformations. PDBs were fitted into maps in UCSF Chimera v1.16 (<xref ref-type="bibr" rid="R28">Pettersen <italic>et al</italic>, 2004</xref>). Manual model rebuilding was performed in Coot 0.9.8 (<xref ref-type="bibr" rid="R5">Casanal <italic>et al</italic>, 2020</xref>). Stereochemistry of the manually built models were optimized using Namdinator (<ext-link ext-link-type="uri" xlink:href="https://namdinator.au.dk">https://namdinator.au.dk</ext-link>) (<xref ref-type="bibr" rid="R18">Kidmose <italic>et al</italic>, 2019</xref>). Final models were refined in PHENIX v1.19.1 (<xref ref-type="bibr" rid="R1">Afonine <italic>et al</italic>, 2018</xref>) by real space refinement with secondary structure restraints and geometry restraints. All structural figures were generated using UCSF Chimera v1.16.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Figures</label><media xlink:href="EMS155875-supplement-Supplementary_Figures.pdf" mimetype="application" mime-subtype="pdf" id="d7aAdDbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S20"><title>Acknowledgements</title><p>We thank Katarzyna Ciazynska, Andrew Carter (MRC-LMB, Cambridge, UK) and John Briggs (Max Planck Institute of Biochemistry, Martinsried, Germany) for initial design of constructs and development of protein production protocols. We thank Kun Qu (Yong Loo Lin School of Medicine, National University of Singapore) for assistance in cryo-EM data processing. This study was supported by the Guangdong-Hong Kong-Macau Joint Laboratory of Respiratory Infectious Diseases (2019B121205010 to JH) and Natural Science Fund of Guangdong Province (2021A1515011289 to XX), National Natural Science Foundation of China (2021000192 to XX). XX acknowledges start-up grants from the Chinese Academy of Sciences and Bioland Laboratory (GRMH-GL).</p></ack><fn-group><fn id="FN2" fn-type="con"><p id="P39"><bold>Author contributions</bold></p><p id="P40">X.X conceived the study; X.Z. expressed and purified spikes for cryo-EM and other experiments based protein production protocols developed by X.X.; X.Z. performed negative stain EM with assistance from B.L., Q.C., X.Zhong and L.J.; X.Z. performed spike reduction experiments with assistance from Q.C.; Y.Z. and Q.W. performed animal experiments under the supervision of L.C. and J.Z.; Y.Z. performed pseudovirus neutralization assays under the supervision of J.Z.; X.Z. prepared cryo-EM grids with assistance from Y.L. and J.W.; Y.L., L.F., X.Z. and J.W. collected cryo-EM data under the supervision of P.W. and J.H.; Z.L. and X.Z. processed cryo-EM data under the supervision of X.X.; X.Z., Z.L. and X.X. built structure models; X.Z. and X.X. analyzed cryo-EM structures; X.Z and Z.L. prepared figures with assistance from X.X.; X.X., X.Z. wrote the paper with input from all authors.</p></fn></fn-group><ref-list><ref id="R1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afonine</surname><given-names>PV</given-names></name><name><surname>Poon</surname><given-names>BK</given-names></name><name><surname>Read</surname><given-names>RJ</given-names></name><name><surname>Sobolev</surname><given-names>OV</given-names></name><name><surname>Terwilliger</surname><given-names>TC</given-names></name><name><surname>Urzhumtsev</surname><given-names>A</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name></person-group><article-title>Real-space refinement in PHENIX for cryo-EM and crystallography</article-title><source>Acta Crystallographica Section D: Structural Biology</source><year>2018</year><volume>74</volume><fpage>531</fpage><lpage>544</lpage></element-citation></ref><ref id="R2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bangaru</surname><given-names>S</given-names></name><name><surname>Ozorowski</surname><given-names>G</given-names></name><name><surname>Turner</surname><given-names>HL</given-names></name><name><surname>Antanasijevic</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Torres</surname><given-names>JL</given-names></name><name><surname>Diedrich</surname><given-names>JK</given-names></name><name><surname>Tian</surname><given-names>J-HH</given-names></name><name><surname>Portnoff</surname><given-names>AD</given-names></name><etal/></person-group><article-title>Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate</article-title><source>Science</source><year>2020</year><volume>370</volume><fpage>1089</fpage><lpage>1094</lpage></element-citation></ref><ref id="R3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Xiao</surname><given-names>T</given-names></name><name><surname>Peng</surname><given-names>H</given-names></name><name><surname>Sterling</surname><given-names>SM</given-names></name><name><surname>Walsh</surname><given-names>RM</given-names></name><name><surname>Rawson</surname><given-names>S</given-names></name><name><surname>Rits-Volloch</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name></person-group><article-title>Distinct conformational states of SARS-CoV-2 spike protein</article-title><source>Science</source><year>2020</year><volume>369</volume><fpage>1586</fpage><lpage>1592</lpage></element-citation></ref><ref id="R4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carnell</surname><given-names>GW</given-names></name><name><surname>Ciazynska</surname><given-names>KA</given-names></name><name><surname>Wells</surname><given-names>DA</given-names></name><name><surname>Xiong</surname><given-names>X</given-names></name><name><surname>Aguinam</surname><given-names>ET</given-names></name><name><surname>McLaughlin</surname><given-names>SH</given-names></name><name><surname>Mallery</surname><given-names>D</given-names></name><name><surname>Ebrahimi</surname><given-names>S</given-names></name><name><surname>Ceron-Gutierrez</surname><given-names>L</given-names></name><name><surname>Asbach</surname><given-names>B</given-names></name><etal/></person-group><article-title>SARS-CoV-2 Spike Protein Stabilized in the Closed State Induces Potent Neutralizing Responses</article-title><source>Journal of Virology</source><year>2021</year><volume>95</volume><elocation-id>e0020321</elocation-id></element-citation></ref><ref id="R5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casanal</surname><given-names>A</given-names></name><name><surname>Lohkamp</surname><given-names>B</given-names></name><name><surname>Emsley</surname><given-names>P</given-names></name></person-group><article-title>Current developments in Coot for macromolecular model building of Electron Cryo-microscopy and Crystallographic Data</article-title><source>Protein Science</source><year>2020</year><volume>29</volume><fpage>1069</fpage><lpage>1078</lpage></element-citation></ref><ref id="R6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerutti</surname><given-names>G</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Nair</surname><given-names>MS</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Katsamba</surname><given-names>PS</given-names></name><name><surname>Bahna</surname><given-names>F</given-names></name><etal/></person-group><article-title>Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain</article-title><source>Cell Rep</source><year>2021</year><volume>37</volume><elocation-id>109928</elocation-id></element-citation></ref><ref id="R7"><element-citation publication-type="journal"><collab>Coronaviridae Study Group of the International Committee on Taxonomy of Viruses</collab><article-title>The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2</article-title><source>Nature Microbiology</source><year>2020</year><volume>5</volume><fpage>536</fpage><lpage>544</lpage></element-citation></ref><ref id="R8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corti</surname><given-names>D</given-names></name><name><surname>Purcell</surname><given-names>LA</given-names></name><name><surname>Snell</surname><given-names>G</given-names></name><name><surname>Veesler</surname><given-names>D</given-names></name></person-group><article-title>Tackling COVID-19 with neutralizing monoclonal antibodies</article-title><source>Cell</source><year>2021</year><fpage>3086</fpage><lpage>3108</lpage></element-citation></ref><ref id="R9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Shan</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>XX</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>R</given-names></name><name><surname>Hu</surname><given-names>P</given-names></name><etal/></person-group><article-title>An adenovirus-vectored COVID-19 vaccine confers protection from SARS-CoV-2 challenge in rhesus macaques</article-title><source>Nature Communications</source><year>2020</year><volume>11</volume><elocation-id>4207</elocation-id></element-citation></ref><ref id="R10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Dellibovi-Ragheb</surname><given-names>TA</given-names></name><name><surname>Kerviel</surname><given-names>A</given-names></name><name><surname>Pak</surname><given-names>E</given-names></name><name><surname>Qiu</surname><given-names>Q</given-names></name><name><surname>Fisher</surname><given-names>M</given-names></name><name><surname>Takvorian</surname><given-names>PM</given-names></name><name><surname>Bleck</surname><given-names>C</given-names></name><name><surname>Hsu</surname><given-names>VW</given-names></name><name><surname>Fehr</surname><given-names>AR</given-names></name><etal/></person-group><article-title>β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway</article-title><source>Cell</source><year>2020</year><volume>183</volume><fpage>1520</fpage><lpage>1535</lpage><elocation-id>e1514</elocation-id></element-citation></ref><ref id="R11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Godley</surname><given-names>L</given-names></name><name><surname>Pfeifer</surname><given-names>J</given-names></name><name><surname>Steinhauer</surname><given-names>D</given-names></name><name><surname>Ely</surname><given-names>B</given-names></name><name><surname>Shaw</surname><given-names>G</given-names></name><name><surname>Kaufmann</surname><given-names>R</given-names></name><name><surname>Suchanek</surname><given-names>E</given-names></name><name><surname>Pabo</surname><given-names>C</given-names></name><name><surname>Skehel</surname><given-names>JJ</given-names></name><name><surname>Wiley</surname><given-names>DC</given-names></name><etal/></person-group><article-title>Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity</article-title><source>Cell</source><year>1992</year><volume>68</volume><fpage>635</fpage><lpage>645</lpage></element-citation></ref><ref id="R12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grubaugh</surname><given-names>ND</given-names></name><name><surname>Hanage</surname><given-names>WP</given-names></name><name><surname>Rasmussen</surname><given-names>AL</given-names></name></person-group><article-title>Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear</article-title><source>Cell</source><year>2020</year><volume>182</volume><fpage>794</fpage><lpage>795</lpage></element-citation></ref><ref id="R13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gui</surname><given-names>M</given-names></name><name><surname>Song</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Xiang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding</article-title><source>Cell Research</source><year>2017</year><volume>27</volume><fpage>119</fpage><lpage>129</lpage></element-citation></ref><ref id="R14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Hu</surname><given-names>B</given-names></name><name><surname>Si</surname><given-names>HR</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>A</given-names></name><name><surname>Geng</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>HF</given-names></name><name><surname>Yang</surname><given-names>XL</given-names></name><etal/></person-group><article-title>Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor</article-title><source>Emerg Microbes Infect</source><year>2021</year><volume>10</volume><fpage>1507</fpage><lpage>1514</lpage></element-citation></ref><ref id="R15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>SC</given-names></name></person-group><article-title>Viral membrane fusion</article-title><source>Nature Structural &amp; Molecular Biology</source><year>2008</year><volume>15</volume><fpage>690</fpage><lpage>698</lpage></element-citation></ref><ref id="R16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henderson</surname><given-names>R</given-names></name><name><surname>Edwards</surname><given-names>RJ</given-names></name><name><surname>Katayoun</surname><given-names>M</given-names></name><name><surname>Janowska</surname><given-names>K</given-names></name><name><surname>Stalls</surname><given-names>V</given-names></name><name><surname>Gobeil</surname><given-names>SMC</given-names></name><name><surname>Kopp</surname><given-names>M</given-names></name><name><surname>Hsu</surname><given-names>AL</given-names></name><name><surname>Borgnia</surname><given-names>MJ</given-names></name><name><surname>Parks</surname><given-names>R</given-names></name><etal/></person-group><article-title>Controlling the SARS-CoV-2 spike glycoprotein conformation</article-title><source>Nature Structural &amp; Molecular Biology</source><year>2020</year><volume>10</volume><fpage>925</fpage><lpage>933</lpage></element-citation></ref><ref id="R17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ke</surname><given-names>Z</given-names></name><name><surname>Oton</surname><given-names>J</given-names></name><name><surname>Qu</surname><given-names>K</given-names></name><name><surname>Cortese</surname><given-names>M</given-names></name><name><surname>Zila</surname><given-names>V</given-names></name><name><surname>McKeane</surname><given-names>L</given-names></name><name><surname>Nakane</surname><given-names>T</given-names></name><name><surname>Zivanov</surname><given-names>J</given-names></name><name><surname>Neufeldt</surname><given-names>CJ</given-names></name><name><surname>Cerikan</surname><given-names>B</given-names></name><etal/></person-group><article-title>Structures and distributions of SARS-CoV-2 spike proteins on intact virions</article-title><source>Nature</source><year>2020</year><volume>588</volume><fpage>498</fpage><lpage>502</lpage></element-citation></ref><ref id="R18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kidmose</surname><given-names>RT</given-names></name><name><surname>Juhl</surname><given-names>J</given-names></name><name><surname>Nissen</surname><given-names>P</given-names></name><name><surname>Boesen</surname><given-names>T</given-names></name><name><surname>Karlsen</surname><given-names>JL</given-names></name><name><surname>Pedersen</surname><given-names>BP</given-names></name></person-group><article-title>Namdinator - automatic molecular dynamics flexible fitting of structural models into cryo-EM and crystallography experimental maps</article-title><source>IUCrJ</source><year>2019</year><volume>6</volume><fpage>526</fpage><lpage>531</lpage></element-citation></ref><ref id="R19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirchdoerfer</surname><given-names>RN</given-names></name><name><surname>Cottrell</surname><given-names>CA</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Pallesen</surname><given-names>J</given-names></name><name><surname>Yassine</surname><given-names>HM</given-names></name><name><surname>Turner</surname><given-names>HL</given-names></name><name><surname>Corbett</surname><given-names>KS</given-names></name><name><surname>Graham</surname><given-names>BS</given-names></name><name><surname>McLellan</surname><given-names>JS</given-names></name><name><surname>Ward</surname><given-names>AB</given-names></name></person-group><article-title>Pre-fusion structure of a human coronavirus spike protein</article-title><source>Nature</source><year>2016</year><volume>531</volume><fpage>118</fpage><lpage>121</lpage></element-citation></ref><ref id="R20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirchdoerfer</surname><given-names>RN</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Pallesen</surname><given-names>J</given-names></name><name><surname>Wrapp</surname><given-names>D</given-names></name><name><surname>Turner</surname><given-names>HL</given-names></name><name><surname>Cottrell</surname><given-names>CA</given-names></name><name><surname>Corbett</surname><given-names>KS</given-names></name><name><surname>Graham</surname><given-names>BS</given-names></name><name><surname>McLellan</surname><given-names>JS</given-names></name><name><surname>Ward</surname><given-names>AB</given-names></name></person-group><article-title>Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis</article-title><source>Scientific Reports</source><year>2018</year><volume>8</volume><fpage>1</fpage><lpage>11</lpage></element-citation></ref><ref id="R21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korber</surname><given-names>B</given-names></name><name><surname>Fischer</surname><given-names>WM</given-names></name><name><surname>Gnanakaran</surname><given-names>S</given-names></name><name><surname>Yoon</surname><given-names>H</given-names></name><name><surname>Theiler</surname><given-names>J</given-names></name><name><surname>Abfalterer</surname><given-names>W</given-names></name><name><surname>Hengartner</surname><given-names>N</given-names></name><name><surname>Giorgi</surname><given-names>EE</given-names></name><name><surname>Bhattacharya</surname><given-names>T</given-names></name><name><surname>Foley</surname><given-names>B</given-names></name><etal/></person-group><article-title>Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus</article-title><source>Cell</source><year>2020</year><volume>182</volume><fpage>812</fpage><lpage>827</lpage><elocation-id>e819</elocation-id></element-citation></ref><ref id="R22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krammer</surname><given-names>F</given-names></name></person-group><article-title>SARS-CoV-2 vaccines in development</article-title><source>Nature</source><year>2020</year><volume>586</volume><fpage>516</fpage><lpage>527</lpage></element-citation></ref><ref id="R23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>PS</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Wilson</surname><given-names>IA</given-names></name></person-group><article-title>Design and Structure of an Engineered Disulfide-Stabilized Influenza Virus Hemagglutinin Trimer</article-title><source>Journal of Virology</source><year>2015</year><volume>89</volume><fpage>7417</fpage><lpage>7420</lpage></element-citation></ref><ref id="R24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F</given-names></name></person-group><article-title>Structure, Function, and Evolution of Coronavirus Spike Proteins</article-title><source>Annual review of virology</source><year>2016</year><volume>3</volume><fpage>237</fpage><lpage>261</lpage></element-citation></ref><ref id="R25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCallum</surname><given-names>M</given-names></name><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Bowen</surname><given-names>JE</given-names></name><name><surname>Corti</surname><given-names>D</given-names></name><name><surname>Veesler</surname><given-names>D</given-names></name></person-group><article-title>Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation</article-title><source>Nature Structural &amp; Molecular Biology</source><year>2020</year><volume>27</volume><fpage>942</fpage><lpage>949</lpage></element-citation></ref><ref id="R26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLellan</surname><given-names>JS</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Joyce</surname><given-names>MG</given-names></name><name><surname>Sastry</surname><given-names>M</given-names></name><name><surname>Stewart-Jones</surname><given-names>GBE</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Srivatsan</surname><given-names>S</given-names></name><name><surname>Zheng</surname><given-names>A</given-names></name><etal/></person-group><article-title>Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus</article-title><source>Science</source><year>2013</year><volume>342</volume><fpage>592</fpage><lpage>598</lpage></element-citation></ref><ref id="R27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pallesen</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Corbett</surname><given-names>KS</given-names></name><name><surname>Wrapp</surname><given-names>D</given-names></name><name><surname>Kirchdoerfer</surname><given-names>RN</given-names></name><name><surname>Turner</surname><given-names>HL</given-names></name><name><surname>Cottrell</surname><given-names>CA</given-names></name><name><surname>Becker</surname><given-names>MM</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><etal/></person-group><article-title>Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>2017</year><fpage>E7348</fpage><lpage>E7357</lpage></element-citation></ref><ref id="R28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettersen</surname><given-names>EF</given-names></name><name><surname>Goddard</surname><given-names>TD</given-names></name><name><surname>Huang</surname><given-names>CC</given-names></name><name><surname>Couch</surname><given-names>GS</given-names></name><name><surname>Greenblatt</surname><given-names>DM</given-names></name><name><surname>Meng</surname><given-names>EC</given-names></name><name><surname>Ferrin</surname><given-names>TE</given-names></name></person-group><article-title>UCSF Chimera - A visualization system for exploratory research and analysis</article-title><source>Journal of Computational Chemistry</source><year>2004</year><volume>25</volume><fpage>1605</fpage><lpage>1612</lpage></element-citation></ref><ref id="R29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Punjani</surname><given-names>A</given-names></name><name><surname>Rubinstein</surname><given-names>JL</given-names></name><name><surname>Fleet</surname><given-names>DJ</given-names></name><name><surname>Brubaker</surname><given-names>MA</given-names></name></person-group><article-title>cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination</article-title><source>Nature Methods</source><year>2017</year><volume>14</volume><fpage>290</fpage><lpage>296</lpage></element-citation></ref><ref id="R30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Ciazynska</surname><given-names>KA</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Guan</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><etal/></person-group><article-title>Engineered disulfide reveals structural dynamics of locked SARS-CoV-2 spike</article-title><source>PLoS Pathogens</source><year>2022</year><volume>18</volume><elocation-id>e1010583</elocation-id></element-citation></ref><ref id="R31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Geng</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name></person-group><article-title>Computational Insights Into the Effects of the R190K and N121Q Mutations on the SARS-CoV-2 Spike Complex With Biliverdin</article-title><source>Front Mol Biosci</source><year>2021</year><volume>8</volume><elocation-id>791885</elocation-id></element-citation></ref><ref id="R32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosa</surname><given-names>A</given-names></name><name><surname>Pye</surname><given-names>VE</given-names></name><name><surname>Graham</surname><given-names>C</given-names></name><name><surname>Muir</surname><given-names>L</given-names></name><name><surname>Seow</surname><given-names>J</given-names></name><name><surname>Ng</surname><given-names>KW</given-names></name><name><surname>Cook</surname><given-names>NJ</given-names></name><name><surname>Rees-Spear</surname><given-names>C</given-names></name><name><surname>Parker</surname><given-names>E</given-names></name><name><surname>dos Santos</surname><given-names>MS</given-names></name><etal/></person-group><article-title>SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity</article-title><source>Science Advances</source><year>2021</year></element-citation></ref><ref id="R33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>RW</given-names></name><name><surname>Derking</surname><given-names>R</given-names></name><name><surname>Cupo</surname><given-names>A</given-names></name><name><surname>Julien</surname><given-names>JP</given-names></name><name><surname>Yasmeen</surname><given-names>A</given-names></name><name><surname>de Val</surname><given-names>N</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Blattner</surname><given-names>C</given-names></name><name><surname>de la Pena</surname><given-names>AT</given-names></name><name><surname>Korzun</surname><given-names>J</given-names></name><etal/></person-group><article-title>A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies</article-title><source>PLoS Pathogens</source><year>2013</year><volume>9</volume><elocation-id>e1003618</elocation-id></element-citation></ref><ref id="R34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shang</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Geng</surname><given-names>Q</given-names></name><name><surname>Luo</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>F</given-names></name></person-group><article-title>Cryo-EM structure of infectious bronchitis coronavirus spike protein reveals structural and functional evolution of coronavirus spike proteins</article-title><source>PLoS Pathogens</source><year>2018</year><volume>14</volume><fpage>1</fpage><lpage>19</lpage></element-citation></ref><ref id="R35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>W</given-names></name><name><surname>Gui</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Xiang</surname><given-names>Y</given-names></name></person-group><article-title>Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2</article-title><source>PLoS Pathogens</source><year>2018</year><volume>14</volume><fpage>1</fpage><lpage>19</lpage></element-citation></ref><ref id="R36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tegunov</surname><given-names>D</given-names></name><name><surname>Cramer</surname><given-names>P</given-names></name></person-group><article-title>Real-time cryo-electron microscopy data preprocessing with Warp</article-title><source>Nature Methods</source><year>2019</year><volume>16</volume><fpage>1146</fpage><lpage>1152</lpage></element-citation></ref><ref id="R37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toelzer</surname><given-names>C</given-names></name><name><surname>Gupta</surname><given-names>K</given-names></name><name><surname>Yadav</surname><given-names>SKN</given-names></name><name><surname>Borucu</surname><given-names>U</given-names></name><name><surname>Davidson</surname><given-names>AD</given-names></name><name><surname>Kavanagh Williamson</surname><given-names>M</given-names></name><name><surname>Shoemark</surname><given-names>DK</given-names></name><name><surname>Garzoni</surname><given-names>F</given-names></name><name><surname>Staufer</surname><given-names>O</given-names></name><name><surname>Milligan</surname><given-names>R</given-names></name><etal/></person-group><article-title>Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein</article-title><source>Science</source><year>2020</year><volume>370</volume><fpage>725</fpage><lpage>730</lpage></element-citation></ref><ref id="R38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toelzer</surname><given-names>C</given-names></name><name><surname>Gupta</surname><given-names>K</given-names></name><name><surname>Yadav</surname><given-names>SKN</given-names></name><name><surname>Hodgson</surname><given-names>L</given-names></name><name><surname>Williamson</surname><given-names>MK</given-names></name><name><surname>Buzas</surname><given-names>D</given-names></name><name><surname>Borucu</surname><given-names>U</given-names></name><name><surname>Powers</surname><given-names>K</given-names></name><name><surname>Stenner</surname><given-names>R</given-names></name><name><surname>Vasileiou</surname><given-names>K</given-names></name><etal/></person-group><article-title>The Free Fatty Acid-Binding Pocket is a Conserved Hallmark in Pathogenic β-Coronavirus Spike Proteins from SARS-CoV to Omicron</article-title><source>bioRxiv</source><year>2022</year><elocation-id>2022.2004.2022.489083</elocation-id></element-citation></ref><ref id="R39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turoňová</surname><given-names>B</given-names></name><name><surname>Sikora</surname><given-names>M</given-names></name><name><surname>Schürmann</surname><given-names>C</given-names></name><name><surname>Hagen</surname><given-names>WJH</given-names></name><name><surname>Welsch</surname><given-names>S</given-names></name><name><surname>Blanc</surname><given-names>FEC</given-names></name><name><surname>von Bülow</surname><given-names>S</given-names></name><name><surname>Gecht</surname><given-names>M</given-names></name><name><surname>Bagola</surname><given-names>K</given-names></name><name><surname>Hörner</surname><given-names>C</given-names></name><etal/></person-group><article-title>In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges</article-title><source>Science</source><year>2020</year><volume>370</volume><fpage>203</fpage><lpage>208</lpage></element-citation></ref><ref id="R40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Park</surname><given-names>YJ</given-names></name><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Wall</surname><given-names>A</given-names></name><name><surname>McGuire</surname><given-names>AT</given-names></name><name><surname>Veesler</surname><given-names>D</given-names></name></person-group><article-title>Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein</article-title><source>Cell</source><year>2020</year><volume>181</volume><fpage>281</fpage><lpage>292</lpage><elocation-id>e286</elocation-id></element-citation></ref><ref id="R41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Bosch</surname><given-names>B-JJ</given-names></name><name><surname>Frenz</surname><given-names>B</given-names></name><name><surname>Rottier</surname><given-names>PJMM</given-names></name><name><surname>DiMaio</surname><given-names>F</given-names></name><name><surname>Rey</surname><given-names>FA</given-names></name><name><surname>Veesler</surname><given-names>D</given-names></name></person-group><article-title>Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer</article-title><source>Nature</source><year>2016a</year><volume>531</volume><fpage>114</fpage><lpage>117</lpage></element-citation></ref><ref id="R42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Frenz</surname><given-names>B</given-names></name><name><surname>Snijder</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Rey</surname><given-names>FA</given-names></name><name><surname>DiMaio</surname><given-names>F</given-names></name><name><surname>Bosch</surname><given-names>B-JJ</given-names></name><name><surname>Veesler</surname><given-names>D</given-names></name></person-group><article-title>Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy</article-title><source>Nature Structural &amp; Molecular Biology</source><year>2016b</year><volume>23</volume><fpage>899</fpage><lpage>905</lpage></element-citation></ref><ref id="R43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Xiong</surname><given-names>X</given-names></name><name><surname>Park</surname><given-names>YJ</given-names></name><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Snijder</surname><given-names>J</given-names></name><name><surname>Quispe</surname><given-names>J</given-names></name><name><surname>Cameroni</surname><given-names>E</given-names></name><name><surname>Gopal</surname><given-names>R</given-names></name><name><surname>Dai</surname><given-names>M</given-names></name><name><surname>Lanzavecchia</surname><given-names>A</given-names></name><etal/></person-group><article-title>Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion</article-title><source>Cell</source><year>2019</year><volume>176</volume><fpage>1026</fpage><lpage>1039</lpage><elocation-id>e1015</elocation-id></element-citation></ref><ref id="R44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>JJ</given-names></name><name><surname>Paterson</surname><given-names>RG</given-names></name><name><surname>Lamb</surname><given-names>RA</given-names></name><name><surname>Jardetzky</surname><given-names>TS</given-names></name></person-group><article-title>Structure and stabilization of the Hendra virus F glycoprotein in its prefusion form</article-title><source>Proceedings of the National Academy of Sciences</source><year>2016</year><volume>113</volume><fpage>1056</fpage><lpage>1061</lpage></element-citation></ref><ref id="R45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wrapp</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Corbett</surname><given-names>KS</given-names></name><name><surname>Goldsmith</surname><given-names>JA</given-names></name><name><surname>Hsieh</surname><given-names>C-L</given-names></name><name><surname>Abiona</surname><given-names>O</given-names></name><name><surname>Graham</surname><given-names>BS</given-names></name><name><surname>McLellan</surname><given-names>JS</given-names></name></person-group><article-title>Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation</article-title><source>Science</source><year>2020</year><volume>367</volume><fpage>1260</fpage><lpage>1263</lpage></element-citation></ref><ref id="R46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wrobel</surname><given-names>AG</given-names></name><name><surname>Benton</surname><given-names>DJ</given-names></name><name><surname>Xu</surname><given-names>P</given-names></name><name><surname>Calder</surname><given-names>LJ</given-names></name><name><surname>Borg</surname><given-names>A</given-names></name><name><surname>Roustan</surname><given-names>C</given-names></name><name><surname>Martin</surname><given-names>SR</given-names></name><name><surname>Rosenthal</surname><given-names>PB</given-names></name><name><surname>Skehel</surname><given-names>JJ</given-names></name><name><surname>Gamblin</surname><given-names>SJ</given-names></name></person-group><article-title>Structure and binding properties of Pangolin-CoV spike glycoprotein inform the evolution of SARS-CoV-2</article-title><source>Nature Communications</source><year>2021</year><volume>12</volume><fpage>837</fpage></element-citation></ref><ref id="R47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wrobel</surname><given-names>AG</given-names></name><name><surname>Benton</surname><given-names>DJ</given-names></name><name><surname>Xu</surname><given-names>P</given-names></name><name><surname>Roustan</surname><given-names>C</given-names></name><name><surname>Martin</surname><given-names>SR</given-names></name><name><surname>Rosenthal</surname><given-names>PB</given-names></name><name><surname>Skehel</surname><given-names>JJ</given-names></name><name><surname>Gamblin</surname><given-names>SJ</given-names></name></person-group><article-title>SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects</article-title><source>Nature Structural &amp; Molecular Biology</source><year>2020</year><volume>27</volume><fpage>763</fpage><lpage>767</lpage></element-citation></ref><ref id="R48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>X</given-names></name><name><surname>Qu</surname><given-names>K</given-names></name><name><surname>Ciazynska</surname><given-names>KA</given-names></name><name><surname>Hosmillo</surname><given-names>M</given-names></name><name><surname>Carter</surname><given-names>AP</given-names></name><name><surname>Ebrahimi</surname><given-names>S</given-names></name><name><surname>Ke</surname><given-names>Z</given-names></name><name><surname>Scheres</surname><given-names>SHW</given-names></name><name><surname>Bergamaschi</surname><given-names>L</given-names></name><name><surname>Grice</surname><given-names>GL</given-names></name><etal/></person-group><article-title>A thermostable, closed SARS-CoV-2 spike protein trimer</article-title><source>Nature Structural &amp; Molecular Biology</source><year>2020</year><volume>27</volume><fpage>934</fpage><lpage>941</lpage></element-citation></ref><ref id="R49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>X</given-names></name><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Snijder</surname><given-names>J</given-names></name><name><surname>Yoshioka</surname><given-names>C</given-names></name><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>McGuire</surname><given-names>AT</given-names></name><name><surname>Rey</surname><given-names>FA</given-names></name><name><surname>Bosch</surname><given-names>B-J</given-names></name><name><surname>Veesler</surname><given-names>D</given-names></name></person-group><article-title>Glycan Shield and Fusion Activation of a Deltacoronavirus Spike Glycoprotein Fine-Tuned for Enteric Infections</article-title><source>Journal of Virology</source><year>2018</year><volume>92</volume><fpage>e01628</fpage><lpage>01617</lpage></element-citation></ref><ref id="R50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>H</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>N</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Weng</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Molecular Architecture of the SARS-CoV-2 Virus</article-title><source>Cell</source><year>2020</year><volume>183</volume><fpage>730</fpage><lpage>738</lpage><elocation-id>e713</elocation-id></element-citation></ref><ref id="R51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Cao</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Qi</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Lu</surname><given-names>G</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains</article-title><source>Nature Communications</source><year>2017</year><volume>8</volume><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="R52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yurkovetskiy</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Pascal</surname><given-names>KE</given-names></name><name><surname>Tomkins-Tinch</surname><given-names>C</given-names></name><name><surname>Nyalile</surname><given-names>TP</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Baum</surname><given-names>A</given-names></name><name><surname>Diehl</surname><given-names>WE</given-names></name><name><surname>Dauphin</surname><given-names>A</given-names></name><name><surname>Carbone</surname><given-names>C</given-names></name><etal/></person-group><article-title>Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant</article-title><source>Cell</source><year>2020</year><volume>183</volume><fpage>739</fpage><lpage>751</lpage><elocation-id>e738</elocation-id></element-citation></ref><ref id="R53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Cai</surname><given-names>Y</given-names></name><name><surname>Xiao</surname><given-names>T</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>H</given-names></name><name><surname>Sterling</surname><given-names>SM</given-names></name><name><surname>Walsh</surname><given-names>RM</given-names></name><name><surname>Rits-Volloch</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Woosley</surname><given-names>AN</given-names></name><etal/></person-group><article-title>Structural impact on SARS-CoV-2 spike protein by D614G substitution</article-title><source>Science</source><year>2021a</year><volume>372</volume><fpage>525</fpage><lpage>530</lpage></element-citation></ref><ref id="R54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Qiao</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Zeng</surname><given-names>J</given-names></name><name><surname>Shan</surname><given-names>S</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Lan</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution</article-title><source>Nature Communications</source><year>2021b</year><volume>12</volume><fpage>1607</fpage></element-citation></ref><ref id="R55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>MM</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhong</surname><given-names>G</given-names></name><name><surname>Tai</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Yin</surname><given-names>G</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Novel cleavage sites identified in SARS-CoV-2 spike protein reveal mechanism for cathepsin L-facilitated viral infection and treatment strategies</article-title><source>Cell Discovery</source><year>2022</year><volume>8</volume><fpage>53</fpage></element-citation></ref><ref id="R56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>SQ</given-names></name><name><surname>Palovcak</surname><given-names>E</given-names></name><name><surname>Armache</surname><given-names>JP</given-names></name><name><surname>Verba</surname><given-names>KA</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Agard</surname><given-names>DA</given-names></name></person-group><article-title>MotionCor2: Anisotropic correction of beam-induced motion for improved cryo-electron microscopy</article-title><source>Nature Methods</source><year>2017</year><volume>14</volume><fpage>331</fpage><lpage>332</lpage></element-citation></ref><ref id="R57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>T</given-names></name><name><surname>Tsybovsky</surname><given-names>Y</given-names></name><name><surname>Gorman</surname><given-names>J</given-names></name><name><surname>Rapp</surname><given-names>M</given-names></name><name><surname>Cerutti</surname><given-names>G</given-names></name><name><surname>Chuang</surname><given-names>G-Y</given-names></name><name><surname>Katsamba</surname><given-names>PS</given-names></name><name><surname>Sampson</surname><given-names>JM</given-names></name><name><surname>Schön</surname><given-names>A</given-names></name><name><surname>Bimela</surname><given-names>J</given-names></name><etal/></person-group><article-title>Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains</article-title><source>Cell Host &amp; Microbe</source><year>2020</year><volume>28</volume><fpage>867</fpage><lpage>879</lpage><elocation-id>e865</elocation-id></element-citation></ref><ref id="R58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zivanov</surname><given-names>J</given-names></name><name><surname>Nakane</surname><given-names>T</given-names></name><name><surname>Scheres</surname><given-names>SHW</given-names></name></person-group><article-title>Estimation of high-order aberrations and anisotropic magnification from cryo-EM data sets in RELION-3.1</article-title><source>IUCrJ</source><year>2020</year><volume>7</volume><fpage>253</fpage><lpage>267</lpage></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig. 1</label><caption><title>Design, purification and characterization of SARS-CoV-1 S/x1, S/x2 and S/x3 spikes.</title><p><bold>a</bold>, Structure of SARS-CoV-1 spike (PDB: 5X58 (<xref ref-type="bibr" rid="R51">Yuan <italic>et al.</italic>, 2017</xref>)) in closed conformation (left panel). The box indicates the location of the zoomed-in view in the right panel, engineered x1 (S370C and D967C), x2 (G400C and V969C) and x3 (D414C and V969C) disulfides are indicated in the zoomed-in view. <bold>b</bold>, Coomassie-stained SDS-PAGE gels of purified SARS-CoV-1 S/native, S/x1, S/x2 and S/x3 spikes. NR or R indicates protein sample prepared in either non-reducing or reducing condition. M indicates protein marker lanes. <bold>c</bold>, Negative stain EM images of the purified spikes. The white lines indicate a length of 250 Å. <bold>d</bold>, Immunogenic and antigenic characteristics of SARS-CoV-1 spikes. Left panel, SARS-CoV-1 pseudovirus neutralizing titers of S/x3 primed and boosted mouse immune sera. Mean and SEM (error bar) are shown, dashed line represents limit of detection (LOD). ****<italic>P</italic> &lt; 0.0001, <italic>P</italic> values were analyzed by 2-way ANOVA test. Middle panel, binding of S/native, S/x1, S/x2 and S/x3 spikes by the S/x3 boosted mouse immune sera. Right panel, binding of S/native, S/x1, S/x2 and S/x3 spikes by the SARS-CoV-2 S-GSAS/6P boosted mouse immune sera. Binding by immune sera was measured by areas under the curves (AUC) derived from ELISA titration curves (<xref ref-type="supplementary-material" rid="SD1">Fig. S3</xref>). Mean and SEM (error bar) are shown. ns, not significant, <italic>P</italic> values were analyzed by one-way ANOVA test.</p></caption><graphic xlink:href="EMS155875-f001"/></fig><fig id="F2" position="float"><label>Fig. 2</label><caption><title>Cryo-EM structures of SARS-CoV-1 S/x1, S/x2 and S/x3 spikes reveal multiple spike conformations.</title><p><bold>a-h</bold>, Cryo-EM densities are shown for structures determined for SARS-CoV-1 S/x1, S/x2 and S/x3 spikes. Featured protomers within the spike trimer densities are colored. S1 structural domains - NTD, RBD, Domain C, and Domain D are colored blue, light blue, cyan, and green respectively. S2 is colored red with S2 structural elements - S2’, FP (fusion peptide) and FPPR (fusion peptide proximal region) highlighted magenta, orange and yellow respectively. <bold>a-b</bold>, Symmetrical locked-1 and locked-2 conformations identified for S/x1. S/x1 locked-1 conformation has a disordered Domain D-loop and ordered FPPR. Whereas Domain D-loop in S/x1 locked-2 conformation adopts an ordered conformation (Domain D-loop conformation-1) and FPPR is partially ordered. Domain D regions where major structural rearrangement occurs are highlighted within the dashed circles. <bold>c-d</bold>, Asymmetrical locked-112 and locked-211 conformations identified for S/x1 spike. Spike trimers in these conformations are assembled from different combinations of locked-1 and locked-2 protomers. Spike trimers are rotated by 120° to show protomers of different conformations. <bold>e</bold>, S/x1 spike in an asymmetrical closed conformation. The spike is rotated 120° to show structural differences in FPPR between protomers. <bold>f-h</bold>, Symmetrical conformations identified for S/x2 and S/x3 spikes. <bold>i</bold>, A schematic drawing of SARS-CoV-1 spike sequence showing its structural domains and elements.</p></caption><graphic xlink:href="EMS155875-f002"/></fig><fig id="F3" position="float"><label>Fig. 3</label><caption><title>Structural features of spike protein protomers in different conformations.</title><p><bold>a-e</bold>, Representative protomers of different conformation categories and with distinctive features were summarized from structures shown in <xref ref-type="fig" rid="F2">Fig. 2</xref>. Molecular models are shown in Middle panels. Left panels show cryo-EM densities of Domain D and surrounding regions with fitted molecular models. Flexible regions (Domain D-loop) between N602-N627 where structural rearrangements occur are highlighted and indicated by star symbols. Structural features in each structure are shown and indicated. Right panels show lipid binding pockets within SARS-CoV-1 RBDs of different conformations. Hydrophobic amino acid sidechains forming the lipid binding pocket are shown in stick representations. Gating helices from the neighboring RBDs are shown in grey with the head group interacting R395 in stick representations. Lipid binding pockets in S/x1 locked-1 (<bold>a</bold>) and locked-2 (<bold>b</bold>) conformations show clear lipid densities. Lipid binding pockets appear to be unoccupied in S/x2 locked-2 (<bold>c</bold>) and S/x1 closed (<bold>d</bold>-<bold>e</bold>) conformations showing absence of lipid density.</p></caption><graphic xlink:href="EMS155875-f003"/></fig><fig id="F4" position="float"><label>Fig. 4</label><caption><title>Structural rearrangements in Domain D among SARS-CoV-1 spikes of different conformations.</title><p><bold>a</bold>, Domain D and surrounding structural elements in locked-1 conformation. Residues N602-W619 within the Domain D-loop are disordered and represented by a green dashed line. Domain D-loop (residues N602-N627) where structural rearrangements occur between conformations are highlighted by star symbols. Cation-π and π-π interactions in the interdigitation interaction involving Y622, F305, R620 and Y819 are indicated by red dashed lines. Salt bridges are indicated by black dashed lines. Residues involved in featured interactions are highlighted by black labels. Hydrophobic residues (V596, Y598, and I637) within Domain D β-sheets are shown along with transparent molecular surface of Domain D hydrophobic core. A folded and ordered FPPR (yellow) is identified in locked-1 conformation. <bold>b</bold>, Domain D-loop in locked-2 conformation refolds to form ordered structures. A new cation-π interaction (red dashed line) is formed between R306 and W619. FPPR is partially disordered, the interaction between D600 of Domain D and K836 of FPPR is retained (black dashed line). <bold>c-d</bold>, Further refolding of Domain D-loop is observed in closed conformations and hydrophobic residues within the loop pack differently against the Domain D hydrophobic core. Interactions (black and green dashed lines) are formed to stabilize the folded Domain D-loop. <bold>d</bold>, FPPRs are normally disordered in spikes of closed conformation, an ordered extruding FPPR is observed for one protomer of closed S/x1 spike.</p></caption><graphic xlink:href="EMS155875-f004"/></fig><fig id="F5" position="float"><label>Fig. 5</label><caption><title>SARS-CoV-1 and SARS-CoV-2 spikes are highly dynamic adopting multiple shared conformations, other SARSr-CoV spikes exhibit reduced dynamics.</title><p><bold>a-d</bold>, Comparison of SARS-CoV-1 spike S1 portions of different conformations. Structures are shown in ribbon representations. Positions of S1 structural domains remain largely unchanged between locked-1 and locked-2 conformations despite structural rearrangements in Domain D. <bold>b</bold>, An overlap of two S/x1 closed conformations reveals highly similar positions of S1 structural domains. <bold>c-d</bold>, Overlaps of locked-1 and locked-2 conformations to closed conformation reveal a large motion of RBD between locked and closed conformations originating from the bendings in Domain C-D hinge region. <bold>e-f</bold>, Overlaps of SARS-CoV-1 and SARS-CoV-2 spike S1 structures of related conformations to show similarities (PDBs: 7XTZ, 7XU2, 7XU3 (<xref ref-type="bibr" rid="R30">Qu <italic>et al.</italic>, 2022</xref>); 6XM5 (<xref ref-type="bibr" rid="R57">Zhou <italic>et al.</italic>, 2020</xref>)). <bold>i-l</bold>, Overlaps of SARS-CoV-1 and SARSr-CoV spike S1 structures of related conformations to identify similarities (PDBs: 7BBH (<xref ref-type="bibr" rid="R46">Wrobel <italic>et al.</italic>, 2021</xref>); 7CN8, 7CN4 (<xref ref-type="bibr" rid="R54">Zhang <italic>et al.</italic>, 2021b</xref>); 6ZGF (<xref ref-type="bibr" rid="R47">Wrobel <italic>et al.</italic>, 2020</xref>)).</p></caption><graphic xlink:href="EMS155875-f005"/></fig><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Cryo-EM data collection, refinement and validation statistics</title></caption><table frame="hsides" rules="groups" style="border-top: solid #008000; border-bottom: solid #008000"><thead><tr><th align="left" valign="top"/><th align="center" valign="top">S/x1 locked-1 (EMDB-34417) (PDB: 8H0X)</th><th align="center" valign="top">S/x1 locked-112 (EMDB-34418) (PDB: 8H0Y)</th><th align="center" valign="top">S/x1 locked-122 (EMDB-34419) (PDD: 8H0Z)</th><th align="center" valign="top">S/x1 locked-2 (EMDB-34420) (PDB: 8H10)</th><th align="center" valign="top">S/x1 closed (EMDB-34421) (PDB: 8H11)</th></tr></thead><tbody><tr><td align="left" valign="top"><bold>Data collection and processing</bold></td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Magnification</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="center" valign="top">81000</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Voltage (kV)</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="center" valign="top">300</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Electron exposure (e<sup>−</sup>/Å<sup>2</sup>)</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="center" valign="top">50</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Defocus range (μm)</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="center" valign="top">-0.8<sup>~</sup>-2.0</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Pixel size (Å)</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="center" valign="top">1.095</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Symmetry imposed</td><td align="center" valign="top">C3</td><td align="center" valign="top">C1</td><td align="center" valign="top">C1</td><td align="center" valign="top">C3</td><td align="center" valign="top">C1</td></tr><tr><td align="left" valign="top">Initial particle images (no.)</td><td align="center" valign="top">4604239</td><td align="center" valign="top">4604239</td><td align="center" valign="top">4604239</td><td align="center" valign="top">4604239</td><td align="center" valign="top">4604239</td></tr><tr><td align="left" valign="top">Final particle images (no.)</td><td align="center" valign="top">58285</td><td align="center" valign="top">91477</td><td align="center" valign="top">70911</td><td align="center" valign="top">22532</td><td align="center" valign="top">504118</td></tr><tr><td align="left" valign="top">Map resolution (Å)</td><td align="center" valign="top">2.57</td><td align="center" valign="top">2.85</td><td align="center" valign="top">2.99</td><td align="center" valign="top">2.99</td><td align="center" valign="top">2.72</td></tr><tr><td align="left" valign="top">    FSC threshold</td><td align="center" valign="top">0.143</td><td align="center" valign="top">0.143</td><td align="center" valign="top">0.143</td><td align="center" valign="top">0.143</td><td align="center" valign="top">0.143</td></tr><tr><td align="left" valign="top">Map resolution range (Å)</td><td align="center" valign="top">2.46-5.18</td><td align="center" valign="top">2.74-4.74</td><td align="center" valign="top">2.87-4.65</td><td align="center" valign="top">2.85-4.74</td><td align="center" valign="top">2.55-4.92</td></tr><tr><td align="left" valign="top"><bold>Refinement</bold></td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Initial model used (PDB code)</td><td align="center" valign="top">7XTZ</td><td align="center" valign="top">7XTZ/7XU2</td><td align="center" valign="top">7XTZ/7XU2</td><td align="center" valign="top">7XU2</td><td align="center" valign="top">5X58</td></tr><tr><td align="left" valign="top">Model resolution (Å)</td><td align="center" valign="top">2.7</td><td align="center" valign="top">2.9</td><td align="center" valign="top">3.0</td><td align="center" valign="top">3.1</td><td align="center" valign="top">2.8</td></tr><tr><td align="left" valign="top">    FSC threshold</td><td align="center" valign="top">0.5</td><td align="center" valign="top">0.5</td><td align="center" valign="top">0.5</td><td align="center" valign="top">0.5</td><td align="center" valign="top">0.5</td></tr><tr><td align="left" valign="top">Map sharpening <italic>B</italic> factor (Å<sup>2</sup>)</td><td align="center" valign="top">-26</td><td align="center" valign="top">-30</td><td align="center" valign="top">-29</td><td align="center" valign="top">-34</td><td align="center" valign="top">-48</td></tr><tr><td align="left" valign="top">Model composition</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">    Non-hydrogen atoms</td><td align="center" valign="top">24804</td><td align="center" valign="top">24940</td><td align="center" valign="top">24797</td><td align="center" valign="top">24882</td><td align="center" valign="top">23477</td></tr><tr><td align="left" valign="top">    Protein residues</td><td align="center" valign="top">3078</td><td align="center" valign="top">3086</td><td align="center" valign="top">3078</td><td align="center" valign="top">3078</td><td align="center" valign="top">2932</td></tr><tr><td align="left" valign="top">    Ligands</td><td align="center" valign="top">777</td><td align="center" valign="top">833</td><td align="center" valign="top">776</td><td align="center" valign="top">861</td><td align="center" valign="top">560</td></tr><tr><td align="left" valign="top"><italic>B</italic> factors (Å<sup>2</sup>)</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">    Protein</td><td align="center" valign="top">46.20</td><td align="center" valign="top">64.68</td><td align="center" valign="top">65.79</td><td align="center" valign="top">54.21</td><td align="center" valign="top">38.19</td></tr><tr><td align="left" valign="top">    Ligand</td><td align="center" valign="top">61.70</td><td align="center" valign="top">80.90</td><td align="center" valign="top">81.68</td><td align="center" valign="top">78.21</td><td align="center" valign="top">74.64</td></tr><tr><td align="left" valign="top">R.m.s. deviations</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">    Bond lengths (Å)</td><td align="center" valign="top">0.004</td><td align="center" valign="top">0.003</td><td align="center" valign="top">0.006</td><td align="center" valign="top">0.007</td><td align="center" valign="top">0.004</td></tr><tr><td align="left" valign="top">    Bond angles (°)</td><td align="center" valign="top">0.988</td><td align="center" valign="top">0.73</td><td align="center" valign="top">0.725</td><td align="center" valign="top">1.054</td><td align="center" valign="top">0.665</td></tr><tr><td align="left" valign="top"><bold>Validation</bold></td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">MolProbity score</td><td align="center" valign="top">1.19</td><td align="center" valign="top">1.10</td><td align="center" valign="top">1.20</td><td align="center" valign="top">1.20</td><td align="center" valign="top">1.04</td></tr><tr><td align="left" valign="top">Clashscore</td><td align="center" valign="top">3.31</td><td align="center" valign="top">2.14</td><td align="center" valign="top">4.17</td><td align="center" valign="top">2.98</td><td align="center" valign="top">2.50</td></tr><tr><td align="left" valign="top">Poor rotamers (%)</td><td align="center" valign="top">0.26</td><td align="center" valign="top">0.3</td><td align="center" valign="top">0.3</td><td align="center" valign="top">0.34</td><td align="center" valign="top">0</td></tr><tr><td align="left" valign="top">Ramachandran plot</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">    Favored (%)</td><td align="center" valign="top">97.69</td><td align="center" valign="top">97.46</td><td align="center" valign="top">97.98</td><td align="center" valign="top">97.43</td><td align="center" valign="top">97.97</td></tr><tr><td align="left" valign="top">    Allowed (%)</td><td align="center" valign="top">2.31</td><td align="center" valign="top">2.54</td><td align="center" valign="top">2.02</td><td align="center" valign="top">2.57</td><td align="center" valign="top">2.03</td></tr><tr><td align="left" valign="top">    Disallowed (%)</td><td align="center" valign="top">0</td><td align="center" valign="top">0</td><td align="center" valign="top">0</td><td align="center" valign="top">0</td><td align="center" valign="top">0</td></tr></tbody></table><table frame="hsides" rules="groups" style="border-top: solid #008000; border-bottom: solid #008000"><thead><tr><th align="left" valign="top"/><th align="center" valign="top">S/x2 closed (EMDB-34422) (PDB: 8H12)</th><th align="center" valign="top">S/x2 locked-2 (EMDB-34423) (PDB: 8H13)</th><th align="center" valign="top">S/x3 locked-1 (EMDB-34424) (PDB: 8H14)</th></tr></thead><tbody><tr><td align="left" valign="top"><bold>Data collection and processing</bold></td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Magnification</td><td align="left" valign="top"/><td align="center" valign="top">45000x</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Voltage (kV)</td><td align="left" valign="top"/><td align="center" valign="top">200</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Electron exposure (e<sup>−</sup>/Å<sup>2</sup>)</td><td align="left" valign="top"/><td align="center" valign="top">62</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Defocus range (μm)</td><td align="left" valign="top"/><td align="center" valign="top">-0.8<sup>~</sup>-2.4</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Pixel size (Å)</td><td align="left" valign="top"/><td align="center" valign="top">0.88</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Symmetry imposed</td><td align="center" valign="top">C3</td><td align="center" valign="top">C3</td><td align="center" valign="top">C3</td></tr><tr><td align="left" valign="top">Initial particle images (no.)</td><td align="center" valign="top">967643</td><td align="center" valign="top">967643</td><td align="center" valign="top">82693</td></tr><tr><td align="left" valign="top">Final particle images (no.)</td><td align="center" valign="top">82882</td><td align="center" valign="top">192457</td><td align="center" valign="top">22958</td></tr><tr><td align="left" valign="top">Map resolution (Å)</td><td align="center" valign="top">3.96</td><td align="center" valign="top">3.37</td><td align="center" valign="top">3.28</td></tr><tr><td align="left" valign="top">    FSC threshold</td><td align="center" valign="top">0.143</td><td align="center" valign="top">0.143</td><td align="center" valign="top">0.143</td></tr><tr><td align="left" valign="top">Map resolution range (Å)</td><td align="center" valign="top">3.79<sup>~</sup>9.19</td><td align="center" valign="top">3.26<sup>~</sup>6.92</td><td align="center" valign="top">3.11<sup>~</sup>10.00</td></tr><tr><td align="left" valign="top"><bold>Refinement</bold></td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Initial model used (PDB code)</td><td align="center" valign="top">5x58</td><td align="center" valign="top">7XU2</td><td align="center" valign="top">7XTZ</td></tr><tr><td align="left" valign="top">Model resolution (Å)</td><td align="center" valign="top">4.04</td><td align="center" valign="top">3.45</td><td align="center" valign="top">3.38</td></tr><tr><td align="left" valign="top">    FSC threshold</td><td align="center" valign="top">0.5</td><td align="center" valign="top">0.5</td><td align="center" valign="top">0.5</td></tr><tr><td align="left" valign="top">Map sharpening <italic>B</italic> factor (Å<sup>2</sup>)</td><td align="center" valign="top">-137</td><td align="center" valign="top">-105</td><td align="center" valign="top">-39.5</td></tr><tr><td align="left" valign="top">Model composition</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">    Non-hydrogen atoms</td><td align="center" valign="top">22233</td><td align="center" valign="top">24330</td><td align="center" valign="top">24762</td></tr><tr><td align="left" valign="top">    Protein residues</td><td align="center" valign="top">2793</td><td align="center" valign="top">3036</td><td align="center" valign="top">3075</td></tr><tr><td align="left" valign="top">    Ligands</td><td align="center" valign="top">378</td><td align="center" valign="top">630</td><td align="center" valign="top">777</td></tr><tr><td align="left" valign="top"><italic>B</italic> factors (Å<sup>2</sup>)</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">    Protein</td><td align="center" valign="top">43.73</td><td align="center" valign="top">27.86</td><td align="center" valign="top">25.88</td></tr><tr><td align="left" valign="top">    Ligand</td><td align="center" valign="top">86.83</td><td align="center" valign="top">55.30</td><td align="center" valign="top">46.88</td></tr><tr><td align="left" valign="top">R.m.s. deviations</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">    Bond lengths (Å)</td><td align="center" valign="top">0.004</td><td align="center" valign="top">0.004</td><td align="center" valign="top">0.003</td></tr><tr><td align="left" valign="top">    Bond angles (°)</td><td align="center" valign="top">0.758</td><td align="center" valign="top">1.096</td><td align="center" valign="top">0.597</td></tr><tr><td align="left" valign="top"><bold>Validation</bold></td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">MolProbity score</td><td align="center" valign="top">1.58</td><td align="center" valign="top">1.21</td><td align="center" valign="top">1.05</td></tr><tr><td align="left" valign="top">Clashscore</td><td align="center" valign="top">3.92</td><td align="center" valign="top">2.27</td><td align="center" valign="top">2.03</td></tr><tr><td align="left" valign="top">Poor rotamers (%)</td><td align="center" valign="top">0.08</td><td align="center" valign="top">1.03</td><td align="center" valign="top">0</td></tr><tr><td align="left" valign="top">Ramachandran plot</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">    Favored (%)</td><td align="center" valign="top">93.91</td><td align="center" valign="top">96.79</td><td align="center" valign="top">97.63</td></tr><tr><td align="left" valign="top">    Allowed (%)</td><td align="center" valign="top">6.09</td><td align="center" valign="top">3.21</td><td align="center" valign="top">2.37</td></tr><tr><td align="left" valign="top">    Disallowed (%)</td><td align="center" valign="top">0</td><td align="center" valign="top">0</td><td align="center" valign="top">0</td></tr></tbody></table><table frame="hsides" rules="groups" style="border-top: solid #008000; border-bottom: solid #008000"><thead><tr><th align="left" valign="top"/><th align="center" valign="top">S/native low-pH closed (EMDB-34425) (PDB: 8H15)</th><th align="center" valign="top">S/native low-pH open (EMDB-34426) (PDB: 8H16)</th></tr></thead><tbody><tr><td align="left" valign="top"><bold>Data collection and processing</bold></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Magnification</td><td align="center" valign="top" colspan="2">45000x</td></tr><tr><td align="left" valign="top">Voltage (kV)</td><td align="center" valign="top" colspan="2">200</td></tr><tr><td align="left" valign="top">Electron exposure (e<sup>−</sup>/Å<sup>2</sup>)</td><td align="center" valign="top" colspan="2">60</td></tr><tr><td align="left" valign="top">Defocus range (μm)</td><td align="center" valign="top" colspan="2">-0.8<sup>~</sup>-2.5</td></tr><tr><td align="left" valign="top">Pixel size (Å)</td><td align="center" valign="top" colspan="2">0.88</td></tr><tr><td align="left" valign="top">Symmetry imposed</td><td align="center" valign="top">C3</td><td align="center" valign="top">C1</td></tr><tr><td align="left" valign="top">Initial particle images (no.)</td><td align="center" valign="top">1375445</td><td align="center" valign="top">1375445</td></tr><tr><td align="left" valign="top">Final particle images (no.)</td><td align="center" valign="top">201293</td><td align="center" valign="top">308387</td></tr><tr><td align="left" valign="top">Map resolution (Å)</td><td align="center" valign="top">3.07</td><td align="center" valign="top">3.28</td></tr><tr><td align="left" valign="top">    FSC threshold</td><td align="center" valign="top">0.143</td><td align="center" valign="top">0.143</td></tr><tr><td align="left" valign="top">Map resolution range (Å)</td><td align="center" valign="top">2.95<sup>~</sup>9.13</td><td align="center" valign="top">3.07<sup>~</sup>9.02</td></tr><tr><td align="left" valign="top"><bold>Refinement</bold></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Initial model used (PDB code)</td><td align="center" valign="top">5X58</td><td align="center" valign="top">5X5B</td></tr><tr><td align="left" valign="top">Model resolution (Å)</td><td align="center" valign="top">3.07</td><td align="center" valign="top">3.28</td></tr><tr><td align="left" valign="top">    FSC threshold</td><td align="center" valign="top">0.5</td><td align="center" valign="top">0.5</td></tr><tr><td align="left" valign="top">Map sharpening <italic>B</italic> factor (Å<sup>2</sup>)</td><td align="center" valign="top">-68.5</td><td align="center" valign="top">-63.5</td></tr><tr><td align="left" valign="top">Model composition</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">    Non-hydrogen atoms</td><td align="center" valign="top">22571</td><td align="center" valign="top">20534</td></tr><tr><td align="left" valign="top">    Protein residues</td><td align="center" valign="top">2890</td><td align="center" valign="top">2630</td></tr><tr><td align="left" valign="top">    Ligands</td><td align="center" valign="top">392</td><td align="center" valign="top">0</td></tr><tr><td align="left" valign="top"><italic>B</italic> factors (Å<sup>2</sup>)</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">    Protein</td><td align="center" valign="top">22.64</td><td align="center" valign="top">27.80</td></tr><tr><td align="left" valign="top">    Ligand</td><td align="center" valign="top">49.45</td><td align="center" valign="top">0</td></tr><tr><td align="left" valign="top">R.m.s. deviations</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">    Bond lengths (Å)</td><td align="center" valign="top">0.003</td><td align="center" valign="top">0.004</td></tr><tr><td align="left" valign="top">    Bond angles (°)</td><td align="center" valign="top">0.72</td><td align="center" valign="top">0.82</td></tr><tr><td align="left" valign="top"><bold>Validation</bold></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">    MolProbity score</td><td align="center" valign="top">1.22</td><td align="center" valign="top">1.45</td></tr><tr><td align="left" valign="top">    Clashscore</td><td align="center" valign="top">3.11</td><td align="center" valign="top">4.44</td></tr><tr><td align="left" valign="top">    Poor rotamers (%)</td><td align="center" valign="top">0.12</td><td align="center" valign="top">0.44</td></tr><tr><td align="left" valign="top">Ramachandran plot</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">    Favored (%)</td><td align="center" valign="top">97.41</td><td align="center" valign="top">96.47</td></tr><tr><td align="left" valign="top">    Allowed (%)</td><td align="center" valign="top">2.59</td><td align="center" valign="top">3.53</td></tr><tr><td align="left" valign="top">    Disallowed (%)</td><td align="center" valign="top">0</td><td align="center" valign="top">0</td></tr></tbody></table></table-wrap></floats-group></article>